<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trop Med Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Trop Med Infect Dis</journal-id><journal-id journal-id-type="publisher-id">tropicalmed</journal-id><journal-title-group><journal-title>Tropical Medicine and Infectious Disease</journal-title></journal-title-group><issn pub-type="epub">2414-6366</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998036</article-id><article-id pub-id-type="pmc">PMC11860987</article-id>
<article-id pub-id-type="doi">10.3390/tropicalmed10020032</article-id><article-id pub-id-type="publisher-id">tropicalmed-10-00032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Molecular Detection of <italic toggle="yes">Mycobacterium leprae</italic> and the Process of Infection and Illness in Contacts of Leprosy Patients: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9529-6830</contrib-id><name><surname>Vidal</surname><given-names>Sarah Lamas</given-names></name><xref rid="af1-tropicalmed-10-00032" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7469-9999</contrib-id><name><surname>Batista</surname><given-names>Lav&#x000ed;nia C&#x000e1;ssia Ferreira</given-names></name><xref rid="af2-tropicalmed-10-00032" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9375-2401</contrib-id><name><surname>Lages</surname><given-names>Daniele dos Santos</given-names></name><xref rid="af1-tropicalmed-10-00032" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8739-4713</contrib-id><name><surname>Bortolomai</surname><given-names>Bruna Eduarda</given-names></name><xref rid="af2-tropicalmed-10-00032" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4501-5989</contrib-id><name><surname>Bueno</surname><given-names>Isabela de Caux</given-names></name><xref rid="af3-tropicalmed-10-00032" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Niitsuma</surname><given-names>Eyleen Nabyla Alvarenga</given-names></name><xref rid="af4-tropicalmed-10-00032" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2407-5771</contrib-id><name><surname>de Oliveira</surname><given-names>Nathan Guilherme</given-names></name><xref rid="af2-tropicalmed-10-00032" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Baptista</surname><given-names>Ida Maria Foschiani Dias</given-names></name><xref rid="af2-tropicalmed-10-00032" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9043-3181</contrib-id><name><surname>Lana</surname><given-names>Francisco Carlos F&#x000e9;lix</given-names></name><xref rid="af5-tropicalmed-10-00032" ref-type="aff">5</xref><xref rid="c1-tropicalmed-10-00032" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kasang</surname><given-names>Christa</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Ortu&#x000f1;o-Guti&#x000e9;rrez</surname><given-names>Nimer</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tropicalmed-10-00032"><label>1</label>Postgraduate Program in Nursing, School of Nursing, Federal University of Minas Gerais, Belo Horizonte CEP 30130-100, Minas Gerais, Brazil; <email>sarahlamasvidal@ufmg.br</email> (S.L.V.); <email>daniele-lages@ufmg.br</email> (D.d.S.L.)</aff><aff id="af2-tropicalmed-10-00032"><label>2</label>Lauro de Souza Lima Institute, Bauru CEP 17034-971, S&#x000e3;o Paulo, Brazil; <email>lavinia.ferreira@unesp.br</email> (L.C.F.B.); <email>bruna.bortolomai@unesp.br</email> (B.E.B.); <email>ng.oliveira@unesp.br</email> (N.G.d.O.); <email>imf.baptista@unesp.br</email> (I.M.F.D.B.)</aff><aff id="af3-tropicalmed-10-00032"><label>3</label>School of Nursing, Federal University of Minas Gerais, Belo Horizonte CEP 30130-100, Minas Gerais, Brazil; <email>isabeladecaux@gmail.com</email></aff><aff id="af4-tropicalmed-10-00032"><label>4</label>Federal Institute of Education, Science and Technology of Northern Minas Gerais, Almenara CEP 39900-000, Minas Gerais, Brazil; <email>eyleen.alvarenga@ifnmg.edu.br</email></aff><aff id="af5-tropicalmed-10-00032"><label>5</label>Department of Maternal and Child Nursing and Public Health, School of Nursing, Federal University of Minas Gerais, Belo Horizonte CEP 30130-100, Minas Gerais, Brazil</aff><author-notes><corresp id="c1-tropicalmed-10-00032"><label>*</label>Correspondence: <email>xicolana@ufmg.br</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>32</elocation-id><history><date date-type="received"><day>21</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>16</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Various techniques have been used for the molecular identification of <italic toggle="yes">Mycobacterium leprae</italic> (<italic toggle="yes">M. leprae</italic>). The aim of this review was to identify the relationship between the molecular presence of <italic toggle="yes">M. leprae</italic> and the process of infection and/or illness of contact of leprosy cases. A systematic review was carried out by searching the Medical Literature Analysis and Retrieval System Online (MEDLINE), Cochrane Library, Embase, Scopus, Web of Science and the Latin American and Caribbean Health Sciences Literature (LILACS) databases in January 2024. The studies were selected by two pairs of reviewers. Observational cross-sectional, case&#x02013;control and cohort studies were included. A descriptive synthesis of the results by category was carried out. A total of 443 studies were identified, and 36 were included in the review. Twelve molecular targets were tested to identify the presence of the bacillus. A relationship was established between the identification of <italic toggle="yes">M. leprae</italic> DNA and factors related to the index case, housing characteristics, living conditions, epidemiology and anti-PGL-1 serology. None of the studies identified evaluated the molecular viability of <italic toggle="yes">M. leprae</italic> among contacts. The detection of <italic toggle="yes">M. leprae</italic> DNA alone does not necessarily predict the development of infection or clinical illness among contacts.</p></abstract><kwd-group><kwd>leprosy</kwd><kwd><italic toggle="yes">Mycobacterium leprae</italic></kwd><kwd>epidemiological monitoring</kwd><kwd>molecular epidemiology</kwd><kwd>polymerase chain reaction</kwd></kwd-group><funding-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais</funding-source><award-id>APQ-02660-18</award-id></award-group><funding-statement>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Minas Gerais&#x02014;APQ-02660-18.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-tropicalmed-10-00032"><title>1. Introduction</title><p>The current global strategy against leprosy has a target of zero leprosy, disability and stigma by 2030 [<xref rid="B1-tropicalmed-10-00032" ref-type="bibr">1</xref>]. Despite this, in 2023, diagnoses of new cases in children under 15 years old and people with established physical disability were still being made in some countries, revealing the maintenance of the chain of transmission and late diagnosis [<xref rid="B2-tropicalmed-10-00032" ref-type="bibr">2</xref>].</p><p>The pathogenesis of leprosy initiates after the exposure of a susceptible individual to Mycobacterium leprae (<italic toggle="yes">M. leprae</italic>), which is transmitted by the upper airways and presents high infectivity and low pathogenicity. In this sense, only a portion of the population develops the disease, and the clinical manifestations are largely determined by the immunological response of the individual [<xref rid="B3-tropicalmed-10-00032" ref-type="bibr">3</xref>].</p><p>Leprosy is a spectral disease where the tuberculoid (T) pole [<xref rid="B4-tropicalmed-10-00032" ref-type="bibr">4</xref>] is characterized by a strong cellular mediated immune response against <italic toggle="yes">M. leprae</italic> [<xref rid="B5-tropicalmed-10-00032" ref-type="bibr">5</xref>]. In the opposing pole, the lepromatous (L) leprosy forms [<xref rid="B4-tropicalmed-10-00032" ref-type="bibr">4</xref>], and this occurs in highly susceptible individuals that have a weak cell immune response to the pathogen and a high bacterial load, being considered the main source of infection [<xref rid="B5-tropicalmed-10-00032" ref-type="bibr">5</xref>]. Between the two poles, the intermediate forms are known as borderline [<xref rid="B4-tropicalmed-10-00032" ref-type="bibr">4</xref>].</p><p>Individuals in the L pole usually present more than five skin lesions and/or a positive bacilloscopy, being classified as Multibacillary (MB) patients as per the therapeutic regimen. The individuals with less than five skin lesions and a negative bacilloscopy, that are in the T pole, are classified as Paucibacillary (PB) [<xref rid="B3-tropicalmed-10-00032" ref-type="bibr">3</xref>]. The main pathogenic aspects of leprosy are illustrated in <xref rid="tropicalmed-10-00032-f001" ref-type="fig">Figure 1</xref>.</p><p>Close and prolonged contact with individuals with a high bacillary load favors infection by <italic toggle="yes">M. leprae</italic>. Thus, being in contact with an index case of leprosy entails a greater risk of becoming ill due to exposure to the bacillus [<xref rid="B3-tropicalmed-10-00032" ref-type="bibr">3</xref>].</p><p>To this day, there is no diagnostic test for the disease, which remains essentially clinical [<xref rid="B6-tropicalmed-10-00032" ref-type="bibr">6</xref>]. However, since the sequencing of the bacillus genome [<xref rid="B7-tropicalmed-10-00032" ref-type="bibr">7</xref>], advances have been made in molecular biology techniques for identifying its DNA in clinical samples.</p><p>Conventional PCR and real-time quantitative PCR (qPCR) assays [<xref rid="B8-tropicalmed-10-00032" ref-type="bibr">8</xref>] have been used to amplify different molecular targets of <italic toggle="yes">M. leprae</italic> and identify small numbers of bacilli. In addition, several studies have assessed viability based on RNA identification by quantitative reverse transcriptase PCR (RT-PCR) assays [<xref rid="B9-tropicalmed-10-00032" ref-type="bibr">9</xref>,<xref rid="B10-tropicalmed-10-00032" ref-type="bibr">10</xref>,<xref rid="B11-tropicalmed-10-00032" ref-type="bibr">11</xref>].</p><p>These techniques have been evaluated in research and recommended to support the detection of leprosy cases in field work, in light of the clinical findings [<xref rid="B12-tropicalmed-10-00032" ref-type="bibr">12</xref>], as aids in the diagnosis of cases for confirmation, monitoring of treatment, detection of resistance [<xref rid="B13-tropicalmed-10-00032" ref-type="bibr">13</xref>], as well as to help diagnose leprosy in contacts with clinical suspicion [<xref rid="B6-tropicalmed-10-00032" ref-type="bibr">6</xref>].</p><p>Despite the various techniques currently used for the molecular identification of <italic toggle="yes">M. leprae</italic>, as well as studies regarding people who are in contact with leprosy cases (which document their role as asymptomatic carriers of the bacillus that may contribute to the risk of infection [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]), a major gap still exists regarding the progress made in the molecular biology of <italic toggle="yes">M. leprae</italic> applied to the contacts of leprosy patients and the process of infection and illness in this group. This gap converges with the need to define a test for diagnosing the disease before clinical signs appear, and this review aims to synthesize existing knowledge in order to answer the following question: &#x0201c;What is the relationship between the presence and/or molecular viability of <italic toggle="yes">Mycobacterium leprae</italic> and the process of infection and/or illness of contacts of leprosy cases?&#x0201d;.</p></sec><sec id="sec2-tropicalmed-10-00032"><title>2. Materials and Methods</title><p>The reporting of this systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [<xref rid="B15-tropicalmed-10-00032" ref-type="bibr">15</xref>]. A protocol was drawn up and registered under the code CRD42022381295, and it is available for access on the International Prospective Register of Systematic Reviews (PROSPERO) platform, Centre for Reviews and Dissemination, York, UK.</p><p>The search strategy was defined based on specific terms designed to retrieve studies related to each of these three concepts: leprosy, the molecular presence and viability of <italic toggle="yes">M. leprae</italic>, and transmission among contacts. The terms were selected from the MeSH, DeCS and Emtree controlled vocabularies. Significant free terms were also included. No language, date/period or publication format restrictions were applied. Specific strategies were defined for the following databases: Medical Literature Analysis and Retrieval System Online (MEDLINE) via PubMed, Cochrane Library, Embase, Scopus, Web of Science and Latin American and Caribbean Health Sciences Literature (LILACS) via the regional portal of the Virtual Health Library (VHL). The complete search strategy used in each of the bases is presented in <xref rid="app1-tropicalmed-10-00032" ref-type="app">Supplementary Material Table S1</xref>. The searches were carried out on 22 January 2024. Moreover, on 9 December 2024, a new search was carried out with the official strategies on all six defined databases to verify the existence of recent articles that could attend the inclusion criteria in the present revision.</p><p>The studies retrieved from the databases were selected based on criteria that met the construction of the research question, derived from the PECOT model, in which P is the household or social contacts of patients with leprosy, E is <italic toggle="yes">M. leprae</italic> (molecular presence or viability), C is not applicable, O is infection or illness and T is published descriptive and analytical observational cross-sectional, case&#x02013;control and cohort studies. Furthermore, we included articles written in Portuguese, English or Spanish, as well as articles whose original text had been translated to one of the previously described languages. Articles that could not be retrieved in full-text form, and those that did not present a description of frequency and/or effect and/of predictive measures, were not included.</p><p>The references found were exported to the Rayyan QCRI (Qatar Computing Research Institute) software, Cambridge, MA, USA. They were then added together and duplicates were excluded. The studies were then selected by reading the title and abstract by two pairs of reviewers (SLV and LCFB; DSL and BEB) independently and blinded on the Rayyan platform. Once the selection was complete, the pairs&#x02019; choices were compared and any differences were resolved by a third reviewer (ICB).</p><p>After this first stage, the selected references were entered into the Mendeley Reference Manager software, Elsevier Limited, London, United Kingdom of Great Britain and Northern Ireland, where the reviewers had access to the full text. The full-text selection was carried out by a pair of reviewers (SLV and LCFB) by filling in a spreadsheet created in Microsoft Excel and fed in by each reviewer independently. The comparison was made after the selection had been completed. An agreement between the two reviewers was assessed using the Kappa test, and substantial and significant agreement was observed (Kappa = 0.651; <italic toggle="yes">p</italic> &#x0003c; 0.0001). Disagreements were again resolved by a third reviewer (ENAN).</p><p>The following data were extracted from the eligible studies: authors, year of publication, journal, country, endemicity, study design, study period, population (household or social contact), sample size, comparison group (if any), outcome assessed, other variables included in the study (sex, age group, clinical form of the case, operational classification of the case, etc.), biological material analyzed, collection site, target used, analysis technique, frequency and/or effect measures assessed with confidence interval and <italic toggle="yes">p</italic>-value (if available). The information was entered into a standardized table in two independent entries and then compared to produce a summary of the review.</p><p>The methodological quality of the included studies was assessed using the Newcastle&#x02013;Ottawa Scale (NOS). This scale helps to assess studies in terms of quality, assigning scores based on a star system, ranging from zero to nine stars for case&#x02013;control and cohort studies and from zero to seven stars for cross-sectional studies. The studies are analyzed in relation to selection, comparability and exposure or outcome [<xref rid="B16-tropicalmed-10-00032" ref-type="bibr">16</xref>,<xref rid="B17-tropicalmed-10-00032" ref-type="bibr">17</xref>]. The results were drawn up by aggregating the data extracted into categories and then describing each category in narrative form.</p></sec><sec sec-type="results" id="sec3-tropicalmed-10-00032"><title>3. Results</title><p>The database search resulted in 443 studies. After removing duplicates, 256 titles and abstracts were evaluated. Of these, 65 studies were selected for full-text reading, of which 29 were excluded (<xref rid="app1-tropicalmed-10-00032" ref-type="app">Supplementary Material Table S2</xref>). At the end of the selection process, detailed in <xref rid="tropicalmed-10-00032-f002" ref-type="fig">Figure 2</xref>, 36 studies were considered eligible for this systematic review.</p><p>The 36 studies included were published between 1997 and 2023 and involved eight countries: Argentina, Bangladesh, Brazil, China, Colombia, Ethiopia, India and Indonesia. Most of the publications (52.8%) were carried out in Brazil. The most frequent language among the publications was English, representing 91.7% of all studies. Moreover, two studies were published in Spanish and one was published in Portuguese. With regard to study design, 24 (66.6%) were cross-sectional studies, 10 (27.8%) were cohort studies, one (2.8%) was a case&#x02013;control study and one (2.8%) was a follow-up study.</p><p>Among the types of contacts evaluated, 32 studies (88.9%) evaluated household contacts, three (8.3%) evaluated household and peridomiciliary contacts, and only one study (2.8%) evaluated social contacts, these being schoolchildren. The sample ranged from 18 to 1352.</p><p>The methodological quality of the studies was assessed using the NOS. In the cross-sectional studies, the score ranged from two to six stars (maximum seven), with 13 (54.2%) receiving four stars. In the cohort, follow-up and case&#x02013;control studies, the score ranged from four to eight stars (maximum nine), with the majority (66.7%) achieving five or six stars. The main limitations that negatively impacted the score of the studies included lack of comparability between groups, an insufficient follow-up period and losses during follow-up (<xref rid="app1-tropicalmed-10-00032" ref-type="app">Supplementary Material Table S3</xref>).</p><p>The data extracted from the molecular analyses and the outcomes assessed (<xref rid="app1-tropicalmed-10-00032" ref-type="app">Supplementary Material Table S4</xref>) were grouped and presented in three categories.</p><list list-type="simple"><list-item><p>Category 1&#x02014;<italic toggle="yes">M. leprae</italic> positivity in contacts</p></list-item></list><p>All 36 studies presented results regarding the presence of <italic toggle="yes">M. leprae</italic> among contacts. The majority of studies (n = 23&#x02013;63.9%) assessed the presence of the bacillus using the RLEP sequence [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>,<xref rid="B18-tropicalmed-10-00032" ref-type="bibr">18</xref>,<xref rid="B19-tropicalmed-10-00032" ref-type="bibr">19</xref>,<xref rid="B20-tropicalmed-10-00032" ref-type="bibr">20</xref>,<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00032" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00032" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00032" ref-type="bibr">24</xref>,<xref rid="B25-tropicalmed-10-00032" ref-type="bibr">25</xref>,<xref rid="B26-tropicalmed-10-00032" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00032" ref-type="bibr">27</xref>,<xref rid="B28-tropicalmed-10-00032" ref-type="bibr">28</xref>,<xref rid="B29-tropicalmed-10-00032" ref-type="bibr">29</xref>,<xref rid="B30-tropicalmed-10-00032" ref-type="bibr">30</xref>,<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>,<xref rid="B32-tropicalmed-10-00032" ref-type="bibr">32</xref>,<xref rid="B33-tropicalmed-10-00032" ref-type="bibr">33</xref>,<xref rid="B34-tropicalmed-10-00032" ref-type="bibr">34</xref>,<xref rid="B35-tropicalmed-10-00032" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00032" ref-type="bibr">36</xref>,<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]. Another five studies (13.9%) identified the 16S rRNA target [<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>,<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>,<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>,<xref rid="B42-tropicalmed-10-00032" ref-type="bibr">42</xref>], while less frequent targets, such as the <italic toggle="yes">pra</italic> [<xref rid="B43-tropicalmed-10-00032" ref-type="bibr">43</xref>,<xref rid="B44-tropicalmed-10-00032" ref-type="bibr">44</xref>], the 12-5 sequence [<xref rid="B45-tropicalmed-10-00032" ref-type="bibr">45</xref>], 36 kDa [<xref rid="B46-tropicalmed-10-00032" ref-type="bibr">46</xref>], the sequence LP1 (5&#x02032;-TGCATGTCATGGCCTTGAGG-3&#x02032;) and LP2 (5&#x02032;-CACCGATACCAGCGGCAGAA-3&#x02032;) [<xref rid="B47-tropicalmed-10-00032" ref-type="bibr">47</xref>], LSR/A15 [<xref rid="B48-tropicalmed-10-00032" ref-type="bibr">48</xref>], S13/S62 [<xref rid="B49-tropicalmed-10-00032" ref-type="bibr">49</xref>], 18 kDa [<xref rid="B50-tropicalmed-10-00032" ref-type="bibr">50</xref>], ML0024 [<xref rid="B51-tropicalmed-10-00032" ref-type="bibr">51</xref>], <italic toggle="yes">sodA</italic> [<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>] and 85B [<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>] were also evaluated. One of the studies did not identify which molecular target was used for the investigation [<xref rid="B52-tropicalmed-10-00032" ref-type="bibr">52</xref>]. It should be noted that three studies evaluated more than one molecular target in their investigation [<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>].</p><list list-type="simple"><list-item><label>1.1.</label><p>Positivity of <italic toggle="yes">M. leprae</italic> from the RLEP sequence</p></list-item></list><p>The prevalence of positivity for <italic toggle="yes">M. leprae</italic> DNA from the RLEP sequence varied widely. The conventional PCR technique had a positivity of 1.7% [<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>] to 72.2% [<xref rid="B27-tropicalmed-10-00032" ref-type="bibr">27</xref>] for nasal swabs, 5.6% [<xref rid="B29-tropicalmed-10-00032" ref-type="bibr">29</xref>] to 6,83% [<xref rid="B30-tropicalmed-10-00032" ref-type="bibr">30</xref>] for oral swabs, 1.7% [<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>] to 6.25% [<xref rid="B20-tropicalmed-10-00032" ref-type="bibr">20</xref>] for blood samples and 3.12% [<xref rid="B19-tropicalmed-10-00032" ref-type="bibr">19</xref>] to 21.43% [<xref rid="B18-tropicalmed-10-00032" ref-type="bibr">18</xref>] in dermal scrapings. When the qPCR technique was performed, positivity for nasal swab samples ranged from 4.7% [<xref rid="B35-tropicalmed-10-00032" ref-type="bibr">35</xref>] to 49% [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>], while, for dermal scrapings, it ranged from 23.7% [<xref rid="B32-tropicalmed-10-00032" ref-type="bibr">32</xref>] to 78.7% [<xref rid="B34-tropicalmed-10-00032" ref-type="bibr">34</xref>]. In palate scraping, it was 31% [<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>].</p><p>Among the studies that tested more than one type of sample for RLEP, the percentage of positivity observed was similar between blood (1.7%) and nasal swabs (1.7%) [<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>], between oral swabs (5.6%) and nasal swabs (4.6%) [<xref rid="B29-tropicalmed-10-00032" ref-type="bibr">29</xref>] and between earlobe dermal scrapings (12.3%) and nasal swabs (18.0%) [<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>]. One study compared three types of samples and found a small difference between nasal swab (49%) and nasal biopsy (53.8%), but these results differed by more than 40% from the positivity found in blood samples (6.7%) [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>].</p><list list-type="simple"><list-item><label>1.2.</label><p>Positivity of <italic toggle="yes">M. leprae</italic> from the 16S target</p></list-item></list><p>Three studies have evaluated the presence of <italic toggle="yes">M. leprae</italic> using the 16S rRNA target [<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>,<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>,<xref rid="B42-tropicalmed-10-00032" ref-type="bibr">42</xref>]. All used the qPCR technique and evaluated dermal scraping samples. One of the studies also evaluated blood samples and found a positivity rate of 9.73% [<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>]. In dermal scrapings, positivity ranged from 9% [<xref rid="B42-tropicalmed-10-00032" ref-type="bibr">42</xref>] to 16.81% [<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>].</p><p>One of these studies evaluated the molecular presence of the bacillus in three different years, observing a progressive decrease in the positivity from 16.81% to 7.04% in the following year and, four years later, to 0%. It is important to note that the number of contacts assessed also decreased over the course of the follow-up process [<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>].</p><list list-type="simple"><list-item><label>1.3.</label><p>Positivity of <italic toggle="yes">M. leprae</italic> from different molecular targets</p></list-item></list><p>Among the studies that evaluated other targets, less frequently than those described above, eight performed conventional PCR, and the prevalence of positivity to <italic toggle="yes">M. leprae</italic> ranged from 0.6% with evaluation of the <italic toggle="yes">pra</italic> gene to [<xref rid="B44-tropicalmed-10-00032" ref-type="bibr">44</xref>] to 31% with the 12-5 sequence [<xref rid="B45-tropicalmed-10-00032" ref-type="bibr">45</xref>].</p><p>Of these, only two studies carried out more than one molecular assessment among contacts, allowing for the presence of <italic toggle="yes">M. leprae</italic> DNA in these individuals to be monitored. One of them evaluated three subsequent months following the treatment of the index case and identified a reduction in the presence of the bacillus among contacts in both nasal swabs and scrapings, with the results showing 0% bacillary DNA among contacts after two months of treatment of the case [<xref rid="B50-tropicalmed-10-00032" ref-type="bibr">50</xref>]. Another study, which carried out an initial assessment and a second one after one year, identified an increase in the prevalence of positivity among contacts in nasal mucosa. However, there were losses during follow-up, and, despite the increase in the percentage of positive results, this positivity was not maintained among the same individuals, indicating that positivity is transitory [<xref rid="B49-tropicalmed-10-00032" ref-type="bibr">49</xref>].</p><p>In two other studies that used the qPCR technique, the prevalence varied from 1.2% for the ML0024 target in blood samples [<xref rid="B51-tropicalmed-10-00032" ref-type="bibr">51</xref>] to 19.35% in nasal biopsies [<xref rid="B52-tropicalmed-10-00032" ref-type="bibr">52</xref>] without specifying the target used.</p><list list-type="simple"><list-item><label>1.4.</label><p>Positivity of <italic toggle="yes">M. leprae</italic> from more than one molecular target</p></list-item></list><p>Three studies evaluated the prevalence of <italic toggle="yes">M. leprae</italic> DNA positivity using more than one molecular target. In all of them, the RLEP was evaluated and showed the highest percentages of positivity [<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>,<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>,<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]. One study compared the positivity percentage in the saliva of households and peridomiciliary contacts for the RLEP and 16S targets, finding greater positivity among peridomiciliary contacts than among those who lived in the same household as the leprosy case [<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>].</p><p>Two other studies evaluated only household contacts. One of them compared the positivity of nasal swabs and palate scrapings for the RLEP and 85B targets and found no significant difference between the two collection sites, indicating that both the nasal mucosa and the oral cavity are equally colonized by the bacillus [<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]. Another study evaluated the RLEP, 16s and <italic toggle="yes">sodA</italic> targets in blood samples, nasal swabs, earlobe dermal scrapings and saliva, identifying positivity only in nasal swabs. Among the molecular targets, the highest positivity was for RLEP (10%), followed by 16S (4%), while <italic toggle="yes">sodA</italic> showed no positivity. When the three targets were evaluated in a single reaction using multiplex PCR, positivity increased considerably to 40% [<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>].</p><p>In <xref rid="tropicalmed-10-00032-t001" ref-type="table">Table 1</xref>, the data extracted in the present study regarding the <italic toggle="yes">M. leprae</italic> positivity in contacts for the RLEP sequence, 16S target and other molecular targets is summarized.</p><list list-type="simple"><list-item><p>Category 2&#x02014;Presence of <italic toggle="yes">M. leprae</italic> and associated factors</p></list-item></list><p>Some studies have found an association between the prevalence of positivity to <italic toggle="yes">M. leprae</italic> and factors related to the index case&#x02019;s [<xref rid="B34-tropicalmed-10-00032" ref-type="bibr">34</xref>] housing characteristics, socializing and epidemiological aspects [<xref rid="B36-tropicalmed-10-00032" ref-type="bibr">36</xref>,<xref rid="B47-tropicalmed-10-00032" ref-type="bibr">47</xref>,<xref rid="B48-tropicalmed-10-00032" ref-type="bibr">48</xref>], as well as positive anti-PGL-1 serology [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>,<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>,<xref rid="B35-tropicalmed-10-00032" ref-type="bibr">35</xref>].</p><p>It was found that contacts of cases classified as BL and LL were more likely to detect <italic toggle="yes">M. leprae</italic> than contacts of TT cases (OR: 6.6; 95% CI: 1.6&#x02013;27.6; <italic toggle="yes">p</italic> = 0.0090). Similarly, contacts of MB cases (OR: 4.88; 95% CI: 1.02&#x02013;23.37; <italic toggle="yes">p</italic> = 0.04) and those with a positive baciloscopic index (BI) (OR: 7.07; 95% CI: 1.41&#x02013;35.41; <italic toggle="yes">p</italic> = 0.0173) also showed greater molecular positivity. In addition, being a genetic contact of the index case further increased the chances of positivity when the case was LL or BL (OR: 9.23; 95% CI: 1.01&#x02013;83.94; <italic toggle="yes">p</italic> = 0.04) and had a positive BI (OR: 6.93; 95% CI: 0.76&#x02013;63.04; <italic toggle="yes">p</italic> = 0.08) [<xref rid="B34-tropicalmed-10-00032" ref-type="bibr">34</xref>].</p><p>When evaluating living with the index case and housing and socioeconomic conditions, it was observed that contacts who had lived with the index case for more than a year were more likely to have the bacillus in their body (OR: 12.45; 95% CI: 1.595&#x02013;97.20; <italic toggle="yes">p</italic> = 0.002) [<xref rid="B47-tropicalmed-10-00032" ref-type="bibr">47</xref>]. In addition, spouses, regardless of the degree of kinship, also had a higher chance of infection compared to other household contacts (OR: 3.87; 95% CI: 1.21&#x02013;12.3) [<xref rid="B48-tropicalmed-10-00032" ref-type="bibr">48</xref>].</p><p>With regard to socioeconomic conditions, a study carried out with social contacts found that living in regions with a poor socioeconomic situation (prevalence ratio (PR): 0.40; 95% CI: 0.18&#x02013;0.91; <italic toggle="yes">p</italic> = 0.039) and living in rented or donated property (PR: 2.16; 95% CI: 1.16&#x02013;4.04; <italic toggle="yes">p</italic> = 0.015) are associated with a greater chance of infection with <italic toggle="yes">M. leprae</italic> [<xref rid="B36-tropicalmed-10-00032" ref-type="bibr">36</xref>].</p><p>Regarding the association with serology, one study found that individuals who had <italic toggle="yes">M. leprae</italic> in nasal biopsy samples also had an immune response identified by anti-PGL-1 serology compared to the others (OR: 4.2; 95% CI: 1.2&#x02013;14.8; <italic toggle="yes">p</italic> = 0.046) [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]. The same association was confirmed in another study which evaluated the detection of <italic toggle="yes">M. leprae</italic> DNA in nasal swabs (<italic toggle="yes">p</italic> &#x0003c; 0.0034) [<xref rid="B35-tropicalmed-10-00032" ref-type="bibr">35</xref>]. Furthermore, the negative correlation identified between RLEP Ct values and serum anti-PGL-1 levels in nasal swab and earlobe dermal scraping samples corroborates this relationship between the presence of bacillus DNA and antibody expression [<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>].</p><list list-type="simple"><list-item><p>Category 3&#x02014;Presence of <italic toggle="yes">M. leprae</italic> and illness among contacts</p></list-item></list><p>Three studies analyzed the association between the identification of <italic toggle="yes">M. leprae</italic> in molecular tests and the illness in contacts. One of them evaluated the presence of the bacillus in the blood and identified a 14 times greater chance of becoming ill in relation to those who were not positive in the molecular evaluation (OR = 14.78; 95% CI: 3.6&#x02013;60.8; <italic toggle="yes">p</italic> &#x0003c; 0.0001) as well as a positive likelihood ratio (LR+) = 13.19 (95% CI: 3.6&#x02013;48.1; <italic toggle="yes">p</italic> &#x0003c; 0.0001) [<xref rid="B51-tropicalmed-10-00032" ref-type="bibr">51</xref>]. Another study found an association between the development of leprosy and positive results in blood samples, with Relative Risk (RR) and LR+ = 5.54 (95% CI: 1.30&#x02013;23.62) [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]. The third study investigated the association between the positivity of <italic toggle="yes">M. leprae</italic> present in dermal scrapings from earlobes and becoming ill, but the RR of 2.52 (95% CI: 0.28&#x02013;22.35) was not statistically significant [<xref rid="B42-tropicalmed-10-00032" ref-type="bibr">42</xref>].</p><p>In addition to these three, ten other studies [<xref rid="B19-tropicalmed-10-00032" ref-type="bibr">19</xref>,<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00032" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00032" ref-type="bibr">23</xref>,<xref rid="B26-tropicalmed-10-00032" ref-type="bibr">26</xref>,<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>,<xref rid="B32-tropicalmed-10-00032" ref-type="bibr">32</xref>,<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>,<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>,<xref rid="B52-tropicalmed-10-00032" ref-type="bibr">52</xref>] identify the occurrence or absence of illness among contacts, but they do not establish a direct relationship with the positivity identified in the molecular tests.</p><p>Among the thirteen studies, the highest percentage of illness identified among contacts was 11.8% [<xref rid="B23-tropicalmed-10-00032" ref-type="bibr">23</xref>], while the lowest was 0% among contacts assessed during a one-year follow-up [<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>].</p></sec><sec sec-type="discussion" id="sec4-tropicalmed-10-00032"><title>4. Discussion</title><p>From the systematic review, it was identified that (a) there is a great diversity of molecular targets already tested to identify <italic toggle="yes">M. leprae</italic> DNA in contacts; (b) none of the studies evaluated investigated the molecular viability of <italic toggle="yes">M. leprae</italic> among contacts; and (c) the studies analyzed do not provide sufficient evidence to correlate the identification of bacillus DNA by a specific molecular target alone with infection and the development of leprosy in contacts.</p><p>Twelve molecular targets were evaluated among the studies included in this review: RLEP, 16S rRNA, pra gene, 12-5 sequence, 36 kDa, sequence LP1 (5&#x02032;-TGCATGTCATGGCCTTGAGG-3&#x02032;) and LP2 (5&#x02032;-CACCGATACCAGCGGCAGAA-3&#x02032;), LSR/A15, S13/S62, 18 kDa, ML0024, sodA and 85B. Of the 36 studies, 63.9% used the RLEP sequence. It also had the highest percentage of positives identified. The high proportion of studies using this sequence may be related to the number of copies of the sequence in the bacillus genome [<xref rid="B53-tropicalmed-10-00032" ref-type="bibr">53</xref>], making it a widely used target.</p><p>Although numerous studies have shown that both the sensitivity and specificity of qPCR are superior to those of conventional PCR [<xref rid="B8-tropicalmed-10-00032" ref-type="bibr">8</xref>,<xref rid="B54-tropicalmed-10-00032" ref-type="bibr">54</xref>], in this review it was not possible to define greater or lesser detections between the two techniques due to the variations in positivity results for <italic toggle="yes">M. leprae</italic> DNA identified in both techniques. However, qPCR enables direct quantification of the DNA content in clinical samples, considerably improving the time taken to obtain the result [<xref rid="B13-tropicalmed-10-00032" ref-type="bibr">13</xref>]. Among the studies evaluated in this review, qPCR has been more widely used in recent years.</p><p>There was also great variability in relation to the biological material analyzed, regardless of the technique used. The efficiency of PCR can be linked to numerous factors other than the type of sample, such as those related to the technique used to collect the material, possible contamination of the samples, pipetting faults [<xref rid="B55-tropicalmed-10-00032" ref-type="bibr">55</xref>] and correct determination of the fluorescence threshold [<xref rid="B56-tropicalmed-10-00032" ref-type="bibr">56</xref>], among other aspects that can affect the result of the molecular evaluation.</p><p>Factors such as being a contact of a case classified as having the most severe form of leprosy and living with the index case for longer and being their spouse increased the chance of the contact having bacillus DNA. It is known that people who develop the most severe forms of the disease have a greater amount of bacillus in their bodies [<xref rid="B6-tropicalmed-10-00032" ref-type="bibr">6</xref>]. In addition, living conditions interfere with the chance of infection by <italic toggle="yes">M. leprae</italic> due to exposure to the bacillus.</p><p>In social contacts, a relationship was observed between the presence of bacillary DNA and poor housing conditions. Leprosy is consistently related to unfavorable socioeconomic conditions [<xref rid="B57-tropicalmed-10-00032" ref-type="bibr">57</xref>,<xref rid="B58-tropicalmed-10-00032" ref-type="bibr">58</xref>], such as living in areas of greater poverty [<xref rid="B58-tropicalmed-10-00032" ref-type="bibr">58</xref>]. Leprosy is a disease historically linked to the individual&#x02019;s social context, which involves both individual and collective aspects [<xref rid="B59-tropicalmed-10-00032" ref-type="bibr">59</xref>]. Factors such as low levels of schooling, food insecurity [<xref rid="B57-tropicalmed-10-00032" ref-type="bibr">57</xref>,<xref rid="B59-tropicalmed-10-00032" ref-type="bibr">59</xref>], being brown or black [<xref rid="B58-tropicalmed-10-00032" ref-type="bibr">58</xref>], living with a case for more than five years, living in the same house as the index case, having overlapping cases in the family [<xref rid="B60-tropicalmed-10-00032" ref-type="bibr">60</xref>] and living with an index case with a high bacillary load [<xref rid="B61-tropicalmed-10-00032" ref-type="bibr">61</xref>] are in line with the findings of the studies included in this review which show a relationship between unfavorable socioeconomic factors and the identification of <italic toggle="yes">M. leprae</italic> DNA among contacts.</p><p>Relationships have also been established between the presence of <italic toggle="yes">M. leprae</italic> DNA and anti-PGL-1 serology. Serological tests are known to be useful in identifying infected individuals in endemic areas [<xref rid="B62-tropicalmed-10-00032" ref-type="bibr">62</xref>] and non-endemic areas [<xref rid="B63-tropicalmed-10-00032" ref-type="bibr">63</xref>] and can be used to screen and identify people at high risk of becoming ill [<xref rid="B64-tropicalmed-10-00032" ref-type="bibr">64</xref>]. Contacts who, as well as having <italic toggle="yes">M. leprae</italic> DNA, already express antibodies to the bacillus, have greater evidence of established infection and a limited cellular immune response.</p><p>The immunological aspects of the person infected by <italic toggle="yes">M. leprae</italic> play an important role in the development of leprosy and, in the manifestation of clinical signs [<xref rid="B65-tropicalmed-10-00032" ref-type="bibr">65</xref>], are taken into account when classifying the disease [<xref rid="B4-tropicalmed-10-00032" ref-type="bibr">4</xref>,<xref rid="B66-tropicalmed-10-00032" ref-type="bibr">66</xref>]. The time between infection and diagnosis favors bacterial proliferation and can lead to the development of physical deformities, aggravating the stigma associated with leprosy [<xref rid="B67-tropicalmed-10-00032" ref-type="bibr">67</xref>].</p><p>Among the studies included in this review, 25 (69.5%) concluded that molecular identification of <italic toggle="yes">M. leprae</italic> DNA indicates infection in these individuals. In the studies that did not link the presence of the bacillus to infection, the results showed that molecular identification allows us to draw conclusions about the colonization of contacts and their role in exposure and transporting of the bacillus.</p><p>Despite the high percentage (69.5%) of articles included in this review that concluded that individuals with bacillus DNA in their bodies were infected, it is important to note that some of them evaluated samples from the upper airways using nasal and oral swabs. These sites are considered to be the bacillus main entry point into the body [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>], indicating bacillus carriers [<xref rid="B68-tropicalmed-10-00032" ref-type="bibr">68</xref>]. This may be linked to the colonization process in which the infectious agent is present without clinical manifestation or immune response.</p><p>However, among those studies that evaluated blood samples, biopsies or dermal scrapings, the possibility of infection can be considered, since the bacilli were successful in the colonization process, overcoming immunological barriers [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]. In light of those studies, we believe that infection is a possible conclusion, considering that a link is made between the presence of signs and symptoms of leprosy or positivity anti-PGL-1 and the outcome infection, which is corroborated by immunological responses.</p><p>Regarding illness in contacts, results were presented in 13 studies, but only 3 of them established a relationship with <italic toggle="yes">M. leprae</italic> DNA positivity. One of them evaluated earlobe dermal scraping samples and showed no statistical significance. Two others evaluated blood samples.</p><p>One of these studies established that the bacillus is identified in the blood of individuals who have had a successful nasal infection process, thus continuing a productive infection and spreading to places where its growth is favored [<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]. The association of the outcome illness and bacillus DNA in blood rather than earlobe scrapings may be related to the technique, since blood collection is more accessible and does not require specialized training [<xref rid="B55-tropicalmed-10-00032" ref-type="bibr">55</xref>].</p><p>It is important to note that most of the studies included in this review had a cross-sectional design, which may have made it impossible to relate the presence of <italic toggle="yes">M. leprae</italic> DNA to the appearance of clinical signs, immune response and the development of the disease.</p><p>Considering the definition of infection as the &#x0201c;penetration, multiplication and/or development of an infectious agent in a given host&#x0201d;, which can also be defined as subclinical infection when it does not cause clinical manifestations [<xref rid="B69-tropicalmed-10-00032" ref-type="bibr">69</xref>], the data obtained in this systematic review make it possible to define that the identification of <italic toggle="yes">M. leprae</italic> DNA in biological samples from leprosy contacts alone does not directly correlate with infection by the bacillus. For this to happen, factors such as the presence of an immune response and the molecular viability of these bacilli must be taken into account.</p><p>Likewise, this relationship cannot be made regarding the outcome illness. Although two studies demonstrated a significant association between the presence of bacillus DNA in blood samples and a greater chance of having leprosy, the use of two different molecular targets limits the definition of that as evidence.</p><p>The detection of <italic toggle="yes">M. leprae</italic> DNA in clinical samples is important and has been recommended among the surveillance actions of the Unified Health System (SUS) since 2022; however, its use is restricted to specialized care in the skin biopsies of contacts already suspected of the disease with inconclusive alterations [<xref rid="B6-tropicalmed-10-00032" ref-type="bibr">6</xref>].</p><p>In addition to the identification of bacillus DNA, detecting <italic toggle="yes">M. leprae</italic> RNA by means of RT-PCR allows for the viability of the bacillus to be assessed, which has already been determined in studies of leprosy cases [<xref rid="B9-tropicalmed-10-00032" ref-type="bibr">9</xref>,<xref rid="B11-tropicalmed-10-00032" ref-type="bibr">11</xref>] and in animal models [<xref rid="B10-tropicalmed-10-00032" ref-type="bibr">10</xref>], and it is also suggested for assessing bacterial load [<xref rid="B11-tropicalmed-10-00032" ref-type="bibr">11</xref>] and identifying the process of infection and illness [<xref rid="B9-tropicalmed-10-00032" ref-type="bibr">9</xref>].</p><p>It is believed to be important to evaluate the molecular viability of <italic toggle="yes">M. leprae</italic> among leprosy contacts, including those without alterations suggestive of the disease, in order to verify its applicability as an early diagnostic tool. Research evaluating bacillus viability targets in household and social contacts from places with different endemicities, as well as in different biological samples, could help define the best model for identifying contacts at greater risk of developing leprosy.</p><p>It should be noted that, although the search strategy was designed to retrieve a wide range of articles, none of the studies identified assessed the viability of <italic toggle="yes">M. leprae</italic> among contacts, which is a limitation of this review. Another limitation refers to the low number of longitudinal studies identified, which highlights the difficulty of following-up contacts of leprosy cases, making it difficult to advance knowledge about the process of infection and becoming ill with leprosy. In this context, the weaknesses of the health services, especially Primary Health Care, in carrying out leprosy control actions also stand out [<xref rid="B70-tropicalmed-10-00032" ref-type="bibr">70</xref>], and these actions involve the monitoring and surveillance of contacts.</p><p>Our results provide insights, since they indicate a demand for new studies, especially those that evaluate molecular viability using RNA samples, thus allowing for the expansion of knowledge regarding the exact relationship between molecular targets and the development of infection and illness.</p><p>We conclude that the detection of <italic toggle="yes">M. leprae</italic> DNA per se does not provide sufficient evidence to link molecular positivity to the development of infection or illness among leprosy contacts.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank the librarian Mariza Talim for developing the search strategies used to carry out this systematic review.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-tropicalmed-10-00032"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/tropicalmed10020032/s1">https://www.mdpi.com/article/10.3390/tropicalmed10020032/s1</uri>. Supplementary Material Table S1&#x02014;Database search strategy. Supplementary Material Table S2&#x02014;Studies excluded after reading the full text. Supplementary Material Table S3&#x02014;General characteristics of the included studies. Supplementary Material Table S4&#x02014;Characteristics of molecular analyses and outcome.</p><supplementary-material id="tropicalmed-10-00032-s001" position="float" content-type="local-data"><media xlink:href="tropicalmed-10-00032-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, F.C.F.L., I.M.F.D.B. and S.L.V.; methodology, B.E.B., D.d.S.L., E.N.A.N., F.C.F.L., I.M.F.D.B., I.d.C.B., L.C.F.B., N.G.d.O. and S.L.V.; software, B.E.B., D.d.S.L., I.d.C.B., L.C.F.B. and S.L.V.; validation, F.C.F.L., I.M.F.D.B. and S.L.V.; formal analysis, B.E.B., D.d.S.L., E.N.A.N., F.C.F.L., I.M.F.D.B., I.d.C.B., L.C.F.B., N.G.d.O. and S.L.V.; investigation, L.C.F.B. and S.L.V.; data curation, F.C.F.L., I.M.F.D.B., L.C.F.B. and S.L.V.; writing&#x02014;original draft preparation, B.E.B., D.d.S.L., E.N.A.N., F.C.F.L., I.M.F.D.B., I.d.C.B., L.C.F.B., N.G.d.O. and S.L.V.; writing&#x02014;review and editing, B.E.B., D.d.S.L., E.N.A.N., F.C.F.L., I.M.F.D.B., I.d.C.B., L.C.F.B., N.G.d.O. and S.L.V.; visualization, F.C.F.L., D.d.S.L., I.M.F.D.B., L.C.F.B. and S.L.V.; supervision, F.C.F.L. and I.M.F.D.B.; project administration, F.C.F.L.; funding acquisition, F.C.F.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in the study are included in the article/<xref rid="app1-tropicalmed-10-00032" ref-type="app">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-tropicalmed-10-00032"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>Organiza&#x000e7;&#x000e3;o Mundial da Sa&#x000fa;de</collab>
</person-group><source>Estrat&#x000e9;gia Global de Hansen&#x000ed;ase 2021&#x02013;2030&#x02014;&#x0201c;Rumo &#x000e0; Zero Hansen&#x000ed;ase&#x0201d;</source><publisher-name>Organiza&#x000e7;&#x000e3;o Mundial da Sa&#x000fa;de, Escrit&#x000f3;rio Regional para o Sudeste Asi&#x000e1;tico</publisher-name><publisher-loc>Nova Delhi, India</publisher-loc><year>2021</year></element-citation></ref><ref id="B2-tropicalmed-10-00032"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group><source>Weekly Epidemiological Record</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2024</year><volume>Volume 99</volume><fpage>497</fpage><lpage>522</lpage></element-citation></ref><ref id="B3-tropicalmed-10-00032"><label>3.</label><element-citation publication-type="gov"><article-title>Brasil Guia de Vigil&#x000e2;ncia Em Sa&#x000fa;de; Minist&#x000e9;rio da Sa&#x000fa;de, Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de. Departamento de Articula&#x000e7;&#x000e3;o Estrat&#x000e9;gica de Vigil&#x000e2;ncia em Sa&#x000fa;de, Eds.; 5th ed rev. e atual; Minist&#x000e9;rio da Sa&#x000fa;de: Bras&#x000ed;lia, Brazil</article-title><year>2021</year><isbn>9786559931026</isbn><comment>Available online: <ext-link xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_5ed_rev_atual.pdf" ext-link-type="uri">https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_5ed_rev_atual.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-01-10">(accessed on 10 January 2024)</date-in-citation></element-citation></ref><ref id="B4-tropicalmed-10-00032"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ridley</surname><given-names>D.S.</given-names></name>
<name><surname>Jopling</surname><given-names>W.H.</given-names></name>
</person-group><article-title>Classification of Leprosy According to Immunity. A Five-Group System</article-title><source>Int. J. Lepr. Other Mycobact. Dis.</source><year>1966</year><volume>34</volume><fpage>255</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">5950347</pub-id>
</element-citation></ref><ref id="B5-tropicalmed-10-00032"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Talhari</surname><given-names>C.</given-names></name>
<name><surname>Talhari</surname><given-names>S.</given-names></name>
<name><surname>Penna</surname><given-names>G.O.</given-names></name>
</person-group><article-title>Clinical Aspects of Leprosy</article-title><source>Clin. Dermatol.</source><year>2015</year><volume>33</volume><fpage>26</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2014.07.002</pub-id><pub-id pub-id-type="pmid">25432808</pub-id>
</element-citation></ref><ref id="B6-tropicalmed-10-00032"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="editor">
<collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab>
<collab>Secretaria de Ci&#x000ea;ncia, Tecnologia, Inova&#x000e7;&#x000e3;o e Insumos Estrat&#x000e9;gicos em Sa&#x000fa;de</collab>
</person-group><source>Brasil Protocolo Cl&#x000ed;nico e Diretrizes Terap&#x000ea;uticas da Hansen&#x000ed;ase</source><publisher-name>Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name><publisher-loc>Bras&#x000ed;lia, Brazil</publisher-loc><year>2022</year></element-citation></ref><ref id="B7-tropicalmed-10-00032"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cole</surname><given-names>S.T.</given-names></name>
<name><surname>Eiglmeier</surname><given-names>K.</given-names></name>
<name><surname>Parkhill</surname><given-names>J.</given-names></name>
<name><surname>James</surname><given-names>K.D.</given-names></name>
<name><surname>Thomson</surname><given-names>N.R.</given-names></name>
<name><surname>Wheeler</surname><given-names>P.R.</given-names></name>
<name><surname>Honor&#x000e9;</surname><given-names>N.</given-names></name>
<name><surname>Garnier</surname><given-names>T.</given-names></name>
<name><surname>Churcher</surname><given-names>C.</given-names></name>
<name><surname>Harris</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Massive Gene Decay in the Leprosy Bacillus</article-title><source>Nature</source><year>2001</year><volume>409</volume><fpage>1007</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1038/35059006</pub-id><pub-id pub-id-type="pmid">11234002</pub-id>
</element-citation></ref><ref id="B8-tropicalmed-10-00032"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>A.N.</given-names></name>
<name><surname>Britto</surname><given-names>C.F.P.C.</given-names></name>
<name><surname>Nery</surname><given-names>J.A.C.</given-names></name>
<name><surname>Sampaio</surname><given-names>E.P.</given-names></name>
<name><surname>Jardim</surname><given-names>M.R.</given-names></name>
<name><surname>Sarno</surname><given-names>E.N.</given-names></name>
<name><surname>Moraes</surname><given-names>M.O.</given-names></name>
</person-group><article-title>Evaluation of Real-Time and Conventional PCR Targeting Complex 85 Genes for Detection of <italic toggle="yes">Mycobacterium leprae</italic> DNA in Skin Biopsy Samples from Patients Diagnosed with Leprosy</article-title><source>J. Clin. Microbiol.</source><year>2006</year><volume>44</volume><fpage>3154</fpage><lpage>3159</lpage><pub-id pub-id-type="doi">10.1128/JCM.02250-05</pub-id><pub-id pub-id-type="pmid">16954241</pub-id>
</element-citation></ref><ref id="B9-tropicalmed-10-00032"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>A.N.</given-names></name>
<name><surname>Lahiri</surname><given-names>R.</given-names></name>
<name><surname>Pittman</surname><given-names>T.L.</given-names></name>
<name><surname>Scollard</surname><given-names>D.</given-names></name>
<name><surname>Truman</surname><given-names>R.</given-names></name>
<name><surname>Moraes</surname><given-names>M.O.</given-names></name>
<name><surname>Williams</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Molecular Determination of <italic toggle="yes">Mycobacterium leprae</italic> Viability by Use of Real-Time PCR</article-title><source>J. Clin. Microbiol.</source><year>2009</year><volume>47</volume><elocation-id>2124</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.00512-09</pub-id><pub-id pub-id-type="pmid">19439537</pub-id>
</element-citation></ref><ref id="B10-tropicalmed-10-00032"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hunter Collins</surname><given-names>J.</given-names></name>
<name><surname>Lenz</surname><given-names>S.M.</given-names></name>
<name><surname>Ray</surname><given-names>N.A.</given-names></name>
<name><surname>Lahiri</surname><given-names>R.</given-names></name>
<name><surname>Adams</surname><given-names>L.B.</given-names></name>
</person-group><article-title>Assessment of EsxA, Hsp18, and 16S Transcript Expression as a Measure of <italic toggle="yes">Mycobacterium leprae</italic> Viability: A Comparison with the Mouse Footpad Assay</article-title><source>Lepr. Rev.</source><year>2023</year><volume>94</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.47276/lr.94.1.7</pub-id></element-citation></ref><ref id="B11-tropicalmed-10-00032"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beissner</surname><given-names>M.</given-names></name>
<name><surname>Woestemeier</surname><given-names>A.</given-names></name>
<name><surname>Saar</surname><given-names>M.</given-names></name>
<name><surname>Badziklou</surname><given-names>K.</given-names></name>
<name><surname>Maman</surname><given-names>I.</given-names></name>
<name><surname>Amedifou</surname><given-names>C.</given-names></name>
<name><surname>Wagner</surname><given-names>M.</given-names></name>
<name><surname>Wiedemann</surname><given-names>F.X.</given-names></name>
<name><surname>Amekuse</surname><given-names>K.</given-names></name>
<name><surname>Kobara</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Development of a Combined RLEP/16S RRNA (RT) QPCR Assay for the Detection of Viable <italic toggle="yes">M. leprae</italic> from Nasal Swab Samples</article-title><source>BMC Infect. Dis.</source><year>2019</year><volume>19</volume><elocation-id>753</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-019-4349-9</pub-id><pub-id pub-id-type="pmid">31462296</pub-id>
</element-citation></ref><ref id="B12-tropicalmed-10-00032"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohanty</surname><given-names>P.S.</given-names></name>
<name><surname>Naaz</surname><given-names>F.</given-names></name>
<name><surname>Bansal</surname><given-names>A.K.</given-names></name>
<name><surname>Kumar</surname><given-names>D.</given-names></name>
<name><surname>Sharma</surname><given-names>S.</given-names></name>
<name><surname>Arora</surname><given-names>M.</given-names></name>
<name><surname>Singh</surname><given-names>H.</given-names></name>
<name><surname>Katara</surname><given-names>P.</given-names></name>
<name><surname>Soni</surname><given-names>N.</given-names></name>
<name><surname>Patil</surname><given-names>S.A.</given-names></name>
<etal/>
</person-group><article-title>Molecular Detection of Mycobacterium Leprae Using RLEP-PCR in Post Elimination Era of Leprosy</article-title><source>Mol. Biol. Res. Commun.</source><year>2020</year><volume>9</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.22099/mbrc.2020.35658.1464</pub-id><pub-id pub-id-type="pmid">32582789</pub-id>
</element-citation></ref><ref id="B13-tropicalmed-10-00032"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>A.N.</given-names></name>
<name><surname>Talhari</surname><given-names>C.</given-names></name>
<name><surname>Moraes</surname><given-names>M.O.</given-names></name>
<name><surname>Talhari</surname><given-names>S.</given-names></name>
</person-group><article-title>PCR-Based Techniques for Leprosy Diagnosis: From the Laboratory to the Clinic</article-title><source>PLoS Negl. Trop. Dis.</source><year>2014</year><volume>8</volume><elocation-id>e2655</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002655</pub-id><pub-id pub-id-type="pmid">24722358</pub-id>
</element-citation></ref><ref id="B14-tropicalmed-10-00032"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Araujo</surname><given-names>S.</given-names></name>
<name><surname>Freitas</surname><given-names>L.O.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<name><surname>Goulart</surname><given-names>I.M.B.</given-names></name>
</person-group><article-title>Molecular Evidence for the Aerial Route of Infection of Mycobacterium Leprae and the Role of Asymptomatic Carriers in the Persistence of Leprosy</article-title><source>Clin. Infect. Dis.</source><year>2016</year><volume>63</volume><fpage>1412</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw570</pub-id><pub-id pub-id-type="pmid">27558564</pub-id>
</element-citation></ref><ref id="B15-tropicalmed-10-00032"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>PRISMA 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n160</fpage><pub-id pub-id-type="doi">10.1136/bmj.n160</pub-id><pub-id pub-id-type="pmid">33781993</pub-id>
</element-citation></ref><ref id="B16-tropicalmed-10-00032"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patra</surname><given-names>J.</given-names></name>
<name><surname>Bhatia</surname><given-names>M.</given-names></name>
<name><surname>Suraweera</surname><given-names>W.</given-names></name>
<name><surname>Morris</surname><given-names>S.K.</given-names></name>
<name><surname>Patra</surname><given-names>C.</given-names></name>
<name><surname>Gupta</surname><given-names>P.C.</given-names></name>
<name><surname>Jha</surname><given-names>P.</given-names></name>
</person-group><article-title>Exposure to Second-Hand Smoke and the Risk of Tuberculosis in Children and Adults: A Systematic Review and Meta-Analysis of 18 Observational Studies</article-title><source>PLoS Med.</source><year>2015</year><volume>12</volume><elocation-id>e1001835</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1001835</pub-id><pub-id pub-id-type="pmid">26035557</pub-id>
</element-citation></ref><ref id="B17-tropicalmed-10-00032"><label>17.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Wells</surname><given-names>G.A.</given-names></name>
<name><surname>Shea</surname><given-names>B.</given-names></name>
<name><surname>O&#x02019;Connell</surname><given-names>D.</given-names></name>
<name><surname>Peterson</surname><given-names>J.</given-names></name>
<name><surname>Welch</surname><given-names>V.</given-names></name>
<name><surname>Losos</surname><given-names>M.</given-names></name>
<name><surname>Tugwell</surname><given-names>P.</given-names></name>
</person-group><article-title>The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses</article-title><comment>Available online: <ext-link xlink:href="https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" ext-link-type="uri">https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-04-20">(accessed on 20 April 2024)</date-in-citation></element-citation></ref><ref id="B18-tropicalmed-10-00032"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Turankar</surname><given-names>R.P.</given-names></name>
<name><surname>Lavania</surname><given-names>M.</given-names></name>
<name><surname>Chaitanya</surname><given-names>V.S.</given-names></name>
<name><surname>Sengupta</surname><given-names>U.</given-names></name>
<name><surname>Darlong</surname><given-names>J.</given-names></name>
<name><surname>Darlong</surname><given-names>F.</given-names></name>
<name><surname>Siva Sai</surname><given-names>K.S.R.</given-names></name>
<name><surname>Jadhav</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Single Nucleotide Polymorphism-Based Molecular Typing of <italic toggle="yes">M. leprae</italic> from Multicase Families of Leprosy Patients and Their Surroundings to Understand the Transmission of Leprosy</article-title><source>Clin. Microbiol. Infect.</source><year>2014</year><volume>20</volume><fpage>O142</fpage><lpage>O149</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12365</pub-id><pub-id pub-id-type="pmid">24520878</pub-id>
</element-citation></ref><ref id="B19-tropicalmed-10-00032"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cardona-Castro</surname><given-names>N.</given-names></name>
<name><surname>Camilo Beltr&#x000e1;n-Alzate</surname><given-names>J.</given-names></name>
<name><surname>Romero-Montoya</surname><given-names>M.</given-names></name>
</person-group><article-title>Clinical, Bacteriological and Immunological Follow-up of Household Contacts of Leprosy Patients from a Post-Elimination Area-Antioquia, Colombia</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2009</year><volume>104</volume><fpage>935</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762009000600021</pub-id><pub-id pub-id-type="pmid">19876571</pub-id>
</element-citation></ref><ref id="B20-tropicalmed-10-00032"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wen</surname><given-names>Y.</given-names></name>
<name><surname>Xing</surname><given-names>Y.</given-names></name>
<name><surname>Yuan</surname><given-names>L.C.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.Y.</given-names></name>
</person-group><article-title>Whole-Blood Nested-PCR Amplification of <italic toggle="yes">M. leprae</italic>-Specific DNA for Early Diagnosis of Leprosy</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2013</year><volume>88</volume><fpage>918</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.11-0253</pub-id><pub-id pub-id-type="pmid">23478578</pub-id>
</element-citation></ref><ref id="B21-tropicalmed-10-00032"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>E.C.D.</given-names></name>
<name><surname>Martinez</surname><given-names>A.N.</given-names></name>
<name><surname>Maniero</surname><given-names>V.C.</given-names></name>
<name><surname>Sales</surname><given-names>A.M.</given-names></name>
<name><surname>Duppre</surname><given-names>N.C.</given-names></name>
<name><surname>Sarno</surname><given-names>N.</given-names></name>
<name><surname>Santos</surname><given-names>A.R.</given-names></name>
<name><surname>Moraes</surname><given-names>M.O.</given-names></name>
</person-group><article-title>Detection of <italic toggle="yes">Mycobacterium leprae</italic> DNA by Polymerase Chain in the Blood and Nasal Secretion of Brazilian Household</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2004</year><volume>99</volume><fpage>509</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762004000500009</pub-id><pub-id pub-id-type="pmid">15543415</pub-id>
</element-citation></ref><ref id="B22-tropicalmed-10-00032"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banerjee</surname><given-names>S.</given-names></name>
<name><surname>Sarkar</surname><given-names>K.</given-names></name>
<name><surname>Gupta</surname><given-names>S.</given-names></name>
<name><surname>Mahapatra</surname><given-names>P.S.</given-names></name>
<name><surname>Gupta</surname><given-names>S.</given-names></name>
<name><surname>Guha</surname><given-names>S.</given-names></name>
<name><surname>Bandhopadhayay</surname><given-names>D.</given-names></name>
<name><surname>Ghosal</surname><given-names>C.</given-names></name>
<name><surname>Paine</surname><given-names>S.K.</given-names></name>
<name><surname>Dutta</surname><given-names>R.N.</given-names></name>
<etal/>
</person-group><article-title>Multiplex PCR Technique Could Be an Alternative Approach for Early Detection of Leprosy among Close Contacts&#x02014;A Pilot Study from India</article-title><source>BMC Infect. Dis.</source><year>2010</year><volume>10</volume><elocation-id>252</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-10-252</pub-id><pub-id pub-id-type="pmid">20735843</pub-id>
</element-citation></ref><ref id="B23-tropicalmed-10-00032"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Barreto</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Avalia&#x000e7;&#x000e3;o de Pacientes Com Hansen&#x000ed;ase Na Faixa Virchowiana Diagnosticados Entre 1990 e 2000 e Tratados Com Poliquimioterapia 24 Doses e Seus Comunicantes Na Fase P&#x000f3;s-Elimina&#x000e7;&#x000e3;o Em Munic&#x000ed;pios de Santa Catarina</article-title><source>Tese (Doutorado)</source><publisher-name>Universidade de S&#x000e3;o Paulo</publisher-name><publisher-loc>S&#x000e3;o Paulo, Brazil</publisher-loc><year>2011</year></element-citation></ref><ref id="B24-tropicalmed-10-00032"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Louren&#x000e7;o</surname><given-names>D.S.D.</given-names></name>
<name><surname>Campelo</surname><given-names>T.A.</given-names></name>
<name><surname>Cruz</surname><given-names>G.A.</given-names></name>
<name><surname>De Almeida</surname><given-names>P.C.</given-names></name>
<name><surname>De S&#x000e1; Gon&#x000e7;alves</surname><given-names>H.</given-names></name>
<name><surname>De Andrade Pontes</surname><given-names>M.A.</given-names></name>
<name><surname>Lima</surname><given-names>L.N.G.C.</given-names></name>
<name><surname>Frota</surname><given-names>C.C.</given-names></name>
</person-group><article-title>Detection of Subclinical <italic toggle="yes">Mycobacterium leprae</italic> Infection in Children, Contacts of Leprosy Cases, Fortaleza&#x02014;Cear&#x000e1;, Brazil</article-title><source>Lepr. Rev.</source><year>2017</year><volume>88</volume><fpage>184</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.47276/lr.88.2.184</pub-id></element-citation></ref><ref id="B25-tropicalmed-10-00032"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medina</surname><given-names>M.G.</given-names></name>
<name><surname>Gim&#x000e9;nez</surname><given-names>M.F.</given-names></name>
<name><surname>Molinari</surname><given-names>M.L.</given-names></name>
<name><surname>L&#x000f3;pez</surname><given-names>M.D.L.A.</given-names></name>
<name><surname>Sorrentino</surname><given-names>A.</given-names></name>
<name><surname>Motta</surname><given-names>P.</given-names></name>
</person-group><article-title>Reacci&#x000f3;n En Cadena de Polimerasa Para Detectar <italic toggle="yes">Mycobacterium leprae</italic> En Muestras de Moco Nasal de Convivientes de Pacientes Con Lepra</article-title><source>Piel</source><year>2010</year><volume>25</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1016/j.piel.2010.05.004</pub-id></element-citation></ref><ref id="B26-tropicalmed-10-00032"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Romero-Montoya</surname><given-names>M.</given-names></name>
<name><surname>Beltran-Alzate</surname><given-names>J.C.</given-names></name>
<name><surname>Cardona-Castro</surname><given-names>N.</given-names></name>
</person-group><article-title>Evaluation and Monitoring of <italic toggle="yes">Mycobacterium leprae</italic> Transmission in Household Contacts of Patients with Hansen&#x02019;s Disease in Colombia</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005325</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005325</pub-id><pub-id pub-id-type="pmid">28114411</pub-id>
</element-citation></ref><ref id="B27-tropicalmed-10-00032"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Silva</surname><given-names>A.R.</given-names></name>
<name><surname>Queiroz</surname><given-names>M.F.A.</given-names></name>
<name><surname>Ishikawa</surname><given-names>E.A.Y.</given-names></name>
<name><surname>Silvestre</surname><given-names>M.D.P.S.A.</given-names></name>
<name><surname>Xavier</surname><given-names>M.B.</given-names></name>
</person-group><article-title>Evaluation of Agreement between Tests for the Diagnosis of Leprosy</article-title><source>J. Bras. Patol. Med. Lab.</source><year>2017</year><volume>53</volume><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.5935/1676-2444.20170014</pub-id></element-citation></ref><ref id="B28-tropicalmed-10-00032"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Urgesa</surname><given-names>K.</given-names></name>
<name><surname>Bobosha</surname><given-names>K.</given-names></name>
<name><surname>Seyoum</surname><given-names>B.</given-names></name>
<name><surname>Weledegbreal</surname><given-names>F.</given-names></name>
<name><surname>Geda</surname><given-names>B.</given-names></name>
<name><surname>Mihret</surname><given-names>A.</given-names></name>
<name><surname>Aseffa</surname><given-names>A.</given-names></name>
</person-group><article-title>High Rate of <italic toggle="yes">Mycobacterium leprae</italic> Infection and Nasal Colonization among Household Contacts of Previously Undiagnosed Leprosy Patients</article-title><source>Lepr. Rev.</source><year>2021</year><volume>92</volume><fpage>276</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.47276/lr.92.3.276</pub-id></element-citation></ref><ref id="B29-tropicalmed-10-00032"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pinho</surname><given-names>J.D.</given-names></name>
<name><surname>Rivas</surname><given-names>P.M.S.</given-names></name>
<name><surname>Mendes</surname><given-names>M.B.P.</given-names></name>
<name><surname>Soares</surname><given-names>R.E.P.</given-names></name>
<name><surname>Costa</surname><given-names>G.C.</given-names></name>
<name><surname>Nascimento</surname><given-names>F.R.F.</given-names></name>
<name><surname>Paiva</surname><given-names>M.F.L.</given-names></name>
<name><surname>Aquino</surname><given-names>D.M.C.</given-names></name>
<name><surname>Figueireido</surname><given-names>I.A.</given-names></name>
<name><surname>Santos</surname><given-names>A.M.</given-names></name>
<etal/>
</person-group><article-title>Presence of <italic toggle="yes">Mycobacterium leprae</italic> DNA and PGL-1 Antigen in Household Contacts of Leprosy Patients from a Hyperendemic Area in Brazil</article-title><source>Genet. Mol. Res.</source><year>2015</year><volume>14</volume><fpage>14479</fpage><lpage>14487</lpage><pub-id pub-id-type="doi">10.4238/2015.November.18.10</pub-id><pub-id pub-id-type="pmid">26600506</pub-id>
</element-citation></ref><ref id="B30-tropicalmed-10-00032"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>T.S.</given-names></name>
<name><surname>Figueira</surname><given-names>M.M.N.R.</given-names></name>
<name><surname>Costa</surname><given-names>A.V.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>M.A.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<name><surname>Goulart</surname><given-names>I.M.B.</given-names></name>
</person-group><article-title>Oral Mucosa as a Source of <italic toggle="yes">Mycobacterium leprae</italic> Infection and Transmission, and Implications of Bacterial DNA Detection and the Immunological Status</article-title><source>Clin. Microbiol. Infect.</source><year>2011</year><volume>17</volume><fpage>1653</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03453.x</pub-id><pub-id pub-id-type="pmid">21199152</pub-id>
</element-citation></ref><ref id="B31-tropicalmed-10-00032"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ti&#x000f3;-Coma</surname><given-names>M.</given-names></name>
<name><surname>Avanzi</surname><given-names>C.</given-names></name>
<name><surname>Verhard</surname><given-names>E.M.</given-names></name>
<name><surname>Pierneef</surname><given-names>L.</given-names></name>
<name><surname>van Hooij</surname><given-names>A.</given-names></name>
<name><surname>Benjak</surname><given-names>A.</given-names></name>
<name><surname>Roy</surname><given-names>J.C.</given-names></name>
<name><surname>Khatun</surname><given-names>M.</given-names></name>
<name><surname>Alam</surname><given-names>K.</given-names></name>
<name><surname>Corstjens</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Genomic Characterization of <italic toggle="yes">Mycobacterium leprae</italic> to Explore Transmission Patterns Identifies New Subtype in Bangladesh</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><elocation-id>1220</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.01220</pub-id><pub-id pub-id-type="pmid">32612587</pub-id>
</element-citation></ref><ref id="B32-tropicalmed-10-00032"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouth</surname><given-names>R.C.</given-names></name>
<name><surname>Gobbo</surname><given-names>A.R.</given-names></name>
<name><surname>Barreto</surname><given-names>J.G.</given-names></name>
<name><surname>do Carmo Pinto</surname><given-names>P.D.</given-names></name>
<name><surname>Bittencourt</surname><given-names>M.S.</given-names></name>
<name><surname>Frade</surname><given-names>M.A.C.</given-names></name>
<name><surname>Nascimento</surname><given-names>A.C.</given-names></name>
<name><surname>Bandeira</surname><given-names>S.S.</given-names></name>
<name><surname>da Costa</surname><given-names>P.F.</given-names></name>
<name><surname>Conde</surname><given-names>G.A.B.</given-names></name>
<etal/>
</person-group><article-title>Specialized Active Leprosy Search Strategies in an Endemic Area of the Brazilian Amazon Identifies a Hypermutated <italic toggle="yes">Mycobacterium leprae</italic> Strain Causing Primary Drug Resistance</article-title><source>Front. Med.</source><year>2023</year><volume>10</volume><elocation-id>1243571</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2023.1243571</pub-id><pub-id pub-id-type="pmid">37780551</pub-id>
</element-citation></ref><ref id="B33-tropicalmed-10-00032"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Da Silva</surname><given-names>M.B.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Bouth</surname><given-names>R.C.</given-names></name>
<name><surname>Gobbo</surname><given-names>A.R.</given-names></name>
<name><surname>Messias</surname><given-names>A.C.C.</given-names></name>
<name><surname>Moraes</surname><given-names>T.M.P.</given-names></name>
<name><surname>Jorge</surname><given-names>E.V.O.</given-names></name>
<name><surname>Barreto</surname><given-names>J.G.</given-names></name>
<name><surname>Filho</surname><given-names>F.B.</given-names></name>
<name><surname>Conde</surname><given-names>G.A.B.</given-names></name>
<etal/>
</person-group><article-title>Latent Leprosy Infection Identified by Dual RLEP and Anti-PGL-I Positivity: Implications for New Control Strategies</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><elocation-id>e0251631</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0251631</pub-id><pub-id pub-id-type="pmid">33984058</pub-id>
</element-citation></ref><ref id="B34-tropicalmed-10-00032"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>M.</given-names></name>
<name><surname>Diana</surname><given-names>D.</given-names></name>
<name><surname>Wedderburn</surname><given-names>A.</given-names></name>
<name><surname>Rajan</surname><given-names>L.</given-names></name>
<name><surname>Rao</surname><given-names>S.</given-names></name>
<name><surname>Horo</surname><given-names>I.</given-names></name>
<name><surname>Vedithi</surname><given-names>S.C.</given-names></name>
</person-group><article-title>Molecular Epidemiology and Transmission Dynamics of Leprosy among Multicase Families and Case-Contact Pairs</article-title><source>Int. J. Infect. Dis.</source><year>2020</year><volume>96</volume><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.04.064</pub-id><pub-id pub-id-type="pmid">32371193</pub-id>
</element-citation></ref><ref id="B35-tropicalmed-10-00032"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ara&#x000fa;jo</surname><given-names>S.</given-names></name>
<name><surname>Lobato</surname><given-names>J.</given-names></name>
<name><surname>Reis</surname><given-names>&#x000c9;.d.M.</given-names></name>
<name><surname>Souza</surname><given-names>D.O.B.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>M.A.</given-names></name>
<name><surname>Costa</surname><given-names>A.V.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<name><surname>Goulart</surname><given-names>I.M.B.</given-names></name>
</person-group><article-title>Unveiling Healthy Carriers and Subclinical Infections among Household Contacts of Leprosy Patients Who Play Potential Roles in the Disease Chain of Transmission</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2012</year><volume>107</volume><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762012000900010</pub-id><pub-id pub-id-type="pmid">23283454</pub-id>
</element-citation></ref><ref id="B36-tropicalmed-10-00032"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sato</surname><given-names>C.M.</given-names></name>
<name><surname>Rodrigues</surname><given-names>T.d.S.V.</given-names></name>
<name><surname>Silva</surname><given-names>P.R.d.S.</given-names></name>
<name><surname>dos Santos</surname><given-names>E.S.</given-names></name>
<name><surname>Xavier</surname><given-names>D.R.</given-names></name>
<name><surname>Baptista</surname><given-names>I.M.F.D.</given-names></name>
<name><surname>Cortela</surname><given-names>D.d.C.B.</given-names></name>
<name><surname>Ignotti</surname><given-names>E.</given-names></name>
<name><surname>Ferreira</surname><given-names>S.M.B.</given-names></name>
</person-group><article-title>Social School Contacts of Multibacillary Leprosy Cases in Children Living in the Hyperendemic Region of the Midwest of Brazil</article-title><source>J. Pediatr.</source><year>2022</year><volume>98</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.jped.2021.11.009</pub-id></element-citation></ref><ref id="B37-tropicalmed-10-00032"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barreto da Silveira</surname><given-names>I.G.d.O.</given-names></name>
<name><surname>da Silva Neto</surname><given-names>J.A.</given-names></name>
<name><surname>da Silva Ferreira</surname><given-names>J.</given-names></name>
<name><surname>Silva</surname><given-names>T.S.</given-names></name>
<name><surname>Holanda</surname><given-names>I.S.A.</given-names></name>
</person-group><article-title>Detection of <italic toggle="yes">Mycobacterium leprae</italic> DNA in Clinical and Environmental Samples Using Serological Analysis and PCR</article-title><source>Mol. Biol. Rep.</source><year>2021</year><volume>48</volume><fpage>6887</fpage><lpage>6895</lpage><pub-id pub-id-type="doi">10.1007/s11033-021-06691-5</pub-id><pub-id pub-id-type="pmid">34463915</pub-id>
</element-citation></ref><ref id="B38-tropicalmed-10-00032"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pathak</surname><given-names>V.K.</given-names></name>
<name><surname>Singh</surname><given-names>I.</given-names></name>
<name><surname>Turankar</surname><given-names>R.P.</given-names></name>
<name><surname>Lavania</surname><given-names>M.</given-names></name>
<name><surname>Ahuja</surname><given-names>M.</given-names></name>
<name><surname>Singh</surname><given-names>V.</given-names></name>
<name><surname>Sengupta</surname><given-names>U.</given-names></name>
</person-group><article-title>Utility of Multiplex PCR for Early Diagnosis and Household Contact Surveillance for Leprosy</article-title><source>Diagn. Microbiol. Infect. Dis.</source><year>2019</year><volume>95</volume><elocation-id>114855</elocation-id><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2019.06.007</pub-id><pub-id pub-id-type="pmid">31285121</pub-id>
</element-citation></ref><ref id="B39-tropicalmed-10-00032"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carvalho</surname><given-names>R.S.</given-names></name>
<name><surname>Foschiani</surname><given-names>I.M.</given-names></name>
<name><surname>Costa</surname><given-names>M.R.S.N.</given-names></name>
<name><surname>Marta</surname><given-names>S.N.</given-names></name>
<name><surname>da Cunha Lopes Virmond</surname><given-names>M.</given-names></name>
</person-group><article-title>Early Detection of M. leprae by QPCR in Untreated Patients and Their Contacts: Results for Nasal Swab and Palate Mucosa Scraping</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2018</year><volume>37</volume><fpage>1863</fpage><lpage>1867</lpage><pub-id pub-id-type="doi">10.1007/s10096-018-3320-9</pub-id><pub-id pub-id-type="pmid">30008126</pub-id>
</element-citation></ref><ref id="B40-tropicalmed-10-00032"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gama</surname><given-names>R.S.</given-names></name>
<name><surname>Gomides</surname><given-names>T.A.R.</given-names></name>
<name><surname>Gama</surname><given-names>C.F.M.</given-names></name>
<name><surname>Moreira</surname><given-names>S.J.M.</given-names></name>
<name><surname>de Neves Manta</surname><given-names>F.S.</given-names></name>
<name><surname>de Oliveira</surname><given-names>L.B.P.</given-names></name>
<name><surname>Mar&#x000e7;al</surname><given-names>P.H.F.</given-names></name>
<name><surname>Sarno</surname><given-names>E.N.</given-names></name>
<name><surname>Moraes</surname><given-names>M.O.</given-names></name>
<name><surname>Garcia</surname><given-names>R.M.G.</given-names></name>
<etal/>
</person-group><article-title>High Frequency of <italic toggle="yes">M. leprae</italic> DNA Detection in Asymptomatic Household Contacts</article-title><source>BMC Infect. Dis.</source><year>2018</year><volume>18</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-018-3056-2</pub-id><pub-id pub-id-type="pmid">29609530</pub-id>
</element-citation></ref><ref id="B41-tropicalmed-10-00032"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gama</surname><given-names>R.S.</given-names></name>
<name><surname>de Souza</surname><given-names>M.L.M.</given-names></name>
<name><surname>Sarno</surname><given-names>E.N.</given-names></name>
<name><surname>de Moraes</surname><given-names>M.O.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>A.</given-names></name>
<name><surname>Stefani</surname><given-names>M.M.A.</given-names></name>
<name><surname>Garcia</surname><given-names>R.M.G.</given-names></name>
<name><surname>Fraga</surname><given-names>L.A.d.O.</given-names></name>
</person-group><article-title>A Novel Integrated Molecular and Serological Analysis Method to Predict New Cases of Leprosy amongst Household Contacts</article-title><source>PLoS Negl. Trop. Dis.</source><year>2019</year><volume>13</volume><elocation-id>e0007400</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0007400</pub-id><pub-id pub-id-type="pmid">31181059</pub-id>
</element-citation></ref><ref id="B42-tropicalmed-10-00032"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Manta</surname><given-names>F.S.N.</given-names></name>
<name><surname>Barbieri</surname><given-names>R.R.</given-names></name>
<name><surname>Moreira</surname><given-names>S.J.M.</given-names></name>
<name><surname>Santos</surname><given-names>P.T.S.</given-names></name>
<name><surname>Nery</surname><given-names>J.A.C.</given-names></name>
<name><surname>Duppre</surname><given-names>N.C.</given-names></name>
<name><surname>Sales</surname><given-names>A.M.</given-names></name>
<name><surname>Pacheco</surname><given-names>A.G.</given-names></name>
<name><surname>Hacker</surname><given-names>M.A.</given-names></name>
<name><surname>Machado</surname><given-names>A.M.</given-names></name>
<etal/>
</person-group><article-title>Quantitative PCR for Leprosy Diagnosis and Monitoring in Household Contacts: A Follow-up Study, 2011&#x02013;2018</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><elocation-id>16675</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-52640-5</pub-id><pub-id pub-id-type="pmid">31723144</pub-id>
</element-citation></ref><ref id="B43-tropicalmed-10-00032"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arunagiri</surname><given-names>K.</given-names></name>
<name><surname>Sangeetha</surname><given-names>G.</given-names></name>
<name><surname>Sugashini</surname><given-names>P.K.</given-names></name>
<name><surname>Balaraman</surname><given-names>S.</given-names></name>
<name><surname>Showkath Ali</surname><given-names>M.K.</given-names></name>
</person-group><article-title>Nasal PCR Assay for the Detection of <italic toggle="yes">Mycobacterium leprae</italic> Pra Gene to Study Subclinical Infection in a Community</article-title><source>Microb. Pathog.</source><year>2017</year><volume>104</volume><fpage>336</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2017.01.046</pub-id><pub-id pub-id-type="pmid">28137508</pub-id>
</element-citation></ref><ref id="B44-tropicalmed-10-00032"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>W.C.S.</given-names></name>
<name><surname>Smith</surname><given-names>C.M.</given-names></name>
<name><surname>Cree</surname><given-names>I.A.</given-names></name>
<name><surname>Jadhav</surname><given-names>R.S.</given-names></name>
<name><surname>Macdonald</surname><given-names>M.</given-names></name>
<name><surname>Edward</surname><given-names>V.K.</given-names></name>
<name><surname>Oskam</surname><given-names>L.</given-names></name>
<name><surname>Van Beers</surname><given-names>S.</given-names></name>
<name><surname>Klatser</surname><given-names>P.</given-names></name>
</person-group><article-title>An Approach to Understanding the Transmission of <italic toggle="yes">Mycobacterium leprae</italic> Using Molecular and Immunological Methods: Results from the MILEP2 Study</article-title><source>Int. J. Lepr.</source><year>2004</year><volume>72</volume><fpage>269</fpage><lpage>277</lpage></element-citation></ref><ref id="B45-tropicalmed-10-00032"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cardona-Castro</surname><given-names>N.</given-names></name>
<name><surname>Beltr&#x000e1;n-Alzate</surname><given-names>J.C.</given-names></name>
<name><surname>Manrique-Hern&#x000e1;ndez</surname><given-names>R.</given-names></name>
</person-group><article-title>Survey to Identify Mycobacterium leprae-Infected Household Contacts of Patients from Prevalent Regions of Leprosy in Colombia</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2008</year><volume>103</volume><fpage>332</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762008000400003</pub-id><pub-id pub-id-type="pmid">18660985</pub-id>
</element-citation></ref><ref id="B46-tropicalmed-10-00032"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cabral</surname><given-names>P.B.e.</given-names></name>
<name><surname>J&#x000fa;nior</surname><given-names>J.E.C.</given-names></name>
<name><surname>Macedo</surname><given-names>A.C.d.</given-names></name>
<name><surname>Alves</surname><given-names>A.R.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>T.B.</given-names></name>
<name><surname>Cabral</surname><given-names>T.C.B.e.</given-names></name>
<name><surname>Gondim</surname><given-names>A.P.S.</given-names></name>
<name><surname>Pinto</surname><given-names>M.I.M.</given-names></name>
<name><surname>Oseki</surname><given-names>K.T.</given-names></name>
<name><surname>Camara</surname><given-names>L.M.C.</given-names></name>
<etal/>
</person-group><article-title>Anti-PGL1 Salivary IgA/IgM, Serum IgG/IgM, and Nasal <italic toggle="yes">Mycobacterium leprae</italic> DNA in Individuals with Household Contact with Leprosy</article-title><source>Int. J. Infect. Dis.</source><year>2013</year><volume>17</volume><fpage>e1005</fpage><lpage>e1010</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2013.05.011</pub-id><pub-id pub-id-type="pmid">23871279</pub-id>
</element-citation></ref><ref id="B47-tropicalmed-10-00032"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krismawati</surname><given-names>H.</given-names></name>
<name><surname>Oktavian</surname><given-names>A.</given-names></name>
<name><surname>Maladan</surname><given-names>Y.</given-names></name>
<name><surname>Wahyuni</surname><given-names>T.</given-names></name>
</person-group><article-title>Risk Factor for <italic toggle="yes">Mycobacterium leprae</italic> Detection in Household Contacts with Leprosy Patients: A Study in Papua, East Indonesia</article-title><source>Med. J. Indones.</source><year>2020</year><volume>29</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.13181/mji.oa.192962</pub-id></element-citation></ref><ref id="B48-tropicalmed-10-00032"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guerrero</surname><given-names>M.I.</given-names></name>
<name><surname>Arias</surname><given-names>M.T.</given-names></name>
<name><surname>Garc&#x000e9;s</surname><given-names>M.T.</given-names></name>
<name><surname>Le&#x000f3;n</surname><given-names>C.I.</given-names></name>
</person-group><article-title>Desarrollo y Aplicaci&#x000f3;n de Una Prueba de RCP Para Detectar La Infecci&#x000f3;n Subcl&#x000ed;nica Por <italic toggle="yes">Mycobacterium leprae</italic> Palabras Clave</article-title><source>Rev. Panam. Salud P&#x000fa;blica</source><year>2002</year><volume>11</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1590/S1020-49892002000400004</pub-id><pub-id pub-id-type="pmid">12049031</pub-id>
</element-citation></ref><ref id="B49-tropicalmed-10-00032"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramaprasad</surname><given-names>P.</given-names></name>
<name><surname>Fernando</surname><given-names>A.</given-names></name>
<name><surname>Madhale</surname><given-names>S.</given-names></name>
<name><surname>Rao</surname><given-names>J.R.</given-names></name>
<name><surname>Edward</surname><given-names>V.K.</given-names></name>
<name><surname>Samson</surname><given-names>P.D.</given-names></name>
<name><surname>Klatsert</surname><given-names>P.R.</given-names></name>
<name><surname>de Witt</surname><given-names>M.Y.</given-names></name>
<name><surname>Smith</surname><given-names>W.C.</given-names></name>
<name><surname>Cree</surname><given-names>I.A.</given-names></name>
</person-group><article-title>Transmission and Protection in Leprosy: Indications of the Role of Mucosal Immunity</article-title><source>Lepr. Rev.</source><year>1997</year><volume>68</volume><fpage>301</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.5935/0305-7518.19970038</pub-id><pub-id pub-id-type="pmid">9503866</pub-id>
</element-citation></ref><ref id="B50-tropicalmed-10-00032"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Job</surname><given-names>C.K.</given-names></name>
<name><surname>Jayakumar</surname><given-names>J.</given-names></name>
<name><surname>Kearney</surname><given-names>M.</given-names></name>
<name><surname>Gillis</surname><given-names>T.P.</given-names></name>
</person-group><article-title>Transmission of Leprosy: A Study of Skin and Nasal Secretions of Household Contacts of Leprosy Patients Using PCR</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2008</year><volume>78</volume><fpage>518</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2008.78.518</pub-id><pub-id pub-id-type="pmid">18337353</pub-id>
</element-citation></ref><ref id="B51-tropicalmed-10-00032"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reis</surname><given-names>E.M.</given-names></name>
<name><surname>Araujo</surname><given-names>S.</given-names></name>
<name><surname>Lobato</surname><given-names>J.</given-names></name>
<name><surname>Neves</surname><given-names>A.F.</given-names></name>
<name><surname>Costa</surname><given-names>A.V.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>M.A.</given-names></name>
<name><surname>Goulart</surname><given-names>L.R.</given-names></name>
<name><surname>Goulart</surname><given-names>I.M.B.</given-names></name>
</person-group><article-title><italic toggle="yes">Mycobacterium leprae</italic> DNA in Peripheral Blood May Indicate a Bacilli Migration Route and High-Risk for Leprosy Onset</article-title><source>Clin. Microbiol. Infect.</source><year>2014</year><volume>20</volume><fpage>447</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12349</pub-id><pub-id pub-id-type="pmid">24033793</pub-id>
</element-citation></ref><ref id="B52-tropicalmed-10-00032"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martins</surname><given-names>A.C.D.C.</given-names></name>
<name><surname>Miranda</surname><given-names>A.</given-names></name>
<name><surname>De Oliveira</surname><given-names>M.L.W.-D.-R.</given-names></name>
<name><surname>B&#x000fc;hrer-S&#x000e9;kula</surname><given-names>S.</given-names></name>
<name><surname>Martinez</surname><given-names>A.</given-names></name>
</person-group><article-title>Nasal Mucosa Study of Leprosy Contacts with Positive Serology for the Phenolic Glycolipid 1 Antigen</article-title><source>Braz. J. Otorhinolaryngol.</source><year>2010</year><volume>76</volume><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1590/S1808-86942010000500008</pub-id><pub-id pub-id-type="pmid">20963340</pub-id>
</element-citation></ref><ref id="B53-tropicalmed-10-00032"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cole</surname><given-names>S.</given-names></name>
<name><surname>Supply</surname><given-names>P.</given-names></name>
<name><surname>Honor&#x000e9;</surname><given-names>N.</given-names></name>
</person-group><article-title>Repetitive Sequences in <italic toggle="yes">Mycobacterium leprae</italic> and Their Impact on Genome Plasticity</article-title><source>Lepr. Rev.</source><year>2001</year><volume>72</volume><fpage>449</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">11826481</pub-id>
</element-citation></ref><ref id="B54-tropicalmed-10-00032"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sarath</surname><given-names>I.M.</given-names></name>
<name><surname>Joseph</surname><given-names>N.M.</given-names></name>
<name><surname>Jamir</surname><given-names>I.</given-names></name>
</person-group><article-title>Quantitative Real-Time Polymerase Chain Reaction for Detection of <italic toggle="yes">Mycobacterium leprae</italic> DNA in Tissue Specimens from Patients with Leprosy</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2023</year><volume>109</volume><fpage>345</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.22-0751</pub-id><pub-id pub-id-type="pmid">37339763</pub-id>
</element-citation></ref><ref id="B55-tropicalmed-10-00032"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruijter</surname><given-names>J.M.</given-names></name>
<name><surname>Barnewall</surname><given-names>R.J.</given-names></name>
<name><surname>Marsh</surname><given-names>I.B.</given-names></name>
<name><surname>Szentirmay</surname><given-names>A.N.</given-names></name>
<name><surname>Quinn</surname><given-names>J.C.</given-names></name>
<name><surname>Van Houdt</surname><given-names>R.</given-names></name>
<name><surname>Gunst</surname><given-names>Q.D.</given-names></name>
<name><surname>Van Den Hoff</surname><given-names>M.J.B.</given-names></name>
</person-group><article-title>Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting</article-title><source>Clin. Chem.</source><year>2021</year><volume>67</volume><fpage>829</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/clinchem/hvab052</pub-id><pub-id pub-id-type="pmid">33890632</pub-id>
</element-citation></ref><ref id="B56-tropicalmed-10-00032"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruiz-Villalba</surname><given-names>A.</given-names></name>
<name><surname>Ruijter</surname><given-names>J.M.</given-names></name>
<name><surname>Van Den Hoff</surname><given-names>M.J.B.</given-names></name>
<name><surname>R&#x000f6;diger</surname><given-names>S.</given-names></name>
<name><surname>Spiess</surname><given-names>A.-N.</given-names></name>
<name><surname>Burdukiewicz</surname><given-names>M.</given-names></name>
</person-group><article-title>Use and Misuse of Cq in QPCR Data Analysis and Reporting</article-title><source>Life</source><year>2021</year><volume>11</volume><elocation-id>496</elocation-id><pub-id pub-id-type="doi">10.3390/life11060496</pub-id><pub-id pub-id-type="pmid">34072308</pub-id>
</element-citation></ref><ref id="B57-tropicalmed-10-00032"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pescarini</surname><given-names>J.M.</given-names></name>
<name><surname>Strina</surname><given-names>A.</given-names></name>
<name><surname>Nery</surname><given-names>J.S.</given-names></name>
<name><surname>Skalinski</surname><given-names>L.M.</given-names></name>
<name><surname>Andrade</surname><given-names>K.V.F.d.</given-names></name>
<name><surname>Penna</surname><given-names>M.L.F.</given-names></name>
<name><surname>Brickley</surname><given-names>E.B.</given-names></name>
<name><surname>Rodrigues</surname><given-names>L.C.</given-names></name>
<name><surname>Barreto</surname><given-names>M.L.</given-names></name>
<name><surname>Penna</surname><given-names>G.O.</given-names></name>
</person-group><article-title>Socioeconomic Risk Markers of Leprosy in High-Burden Countries: A Systematic Review and Meta-Analysis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2018</year><volume>12</volume><elocation-id>e0006622</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0006622</pub-id><pub-id pub-id-type="pmid">29985930</pub-id>
</element-citation></ref><ref id="B58-tropicalmed-10-00032"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nery</surname><given-names>J.S.</given-names></name>
<name><surname>Ramond</surname><given-names>A.</given-names></name>
<name><surname>Pescarini</surname><given-names>J.M.</given-names></name>
<name><surname>Alves</surname><given-names>A.</given-names></name>
<name><surname>Strina</surname><given-names>A.</given-names></name>
<name><surname>Ichihara</surname><given-names>M.Y.</given-names></name>
<name><surname>Fernandes Penna</surname><given-names>M.L.</given-names></name>
<name><surname>Smeeth</surname><given-names>L.</given-names></name>
<name><surname>Rodrigues</surname><given-names>L.C.</given-names></name>
<name><surname>Barreto</surname><given-names>M.L.</given-names></name>
<etal/>
</person-group><article-title>Socioeconomic Determinants of Leprosy New Case Detection in the 100 Million Brazilian Cohort: A Population-Based Linkage Study</article-title><source>Lancet Glob. Health</source><year>2019</year><volume>7</volume><fpage>e1226</fpage><lpage>e1236</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(19)30260-8</pub-id><pub-id pub-id-type="pmid">31331811</pub-id>
</element-citation></ref><ref id="B59-tropicalmed-10-00032"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leano</surname><given-names>H.A.d.M.</given-names></name>
<name><surname>Ara&#x000fa;jo</surname><given-names>K.M.d.F.A.</given-names></name>
<name><surname>Bueno</surname><given-names>I.d.C.</given-names></name>
<name><surname>Niitsuma</surname><given-names>E.N.A.</given-names></name>
<name><surname>Lana</surname><given-names>F.C.F.</given-names></name>
</person-group><article-title>Fatores Socioecon&#x000f4;micos Relacionados &#x000e0; Hansen&#x000ed;ase: Revis&#x000e3;o Integrativa Da Literatura</article-title><source>Rev. Bras. Enferm.</source><year>2019</year><volume>72</volume><fpage>1405</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1590/0034-7167-2017-0651</pub-id><pub-id pub-id-type="pmid">31531668</pub-id>
</element-citation></ref><ref id="B60-tropicalmed-10-00032"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boigny</surname><given-names>R.N.</given-names></name>
<name><surname>de Souza</surname><given-names>E.A.</given-names></name>
<name><surname>Romanholo</surname><given-names>H.S.B.</given-names></name>
<name><surname>de Ara&#x000fa;jo</surname><given-names>O.D.</given-names></name>
<name><surname>de Ara&#x000fa;jo</surname><given-names>T.M.E.</given-names></name>
<name><surname>Carneiro</surname><given-names>M.A.G.</given-names></name>
<name><surname>Grij&#x000f3;</surname><given-names>M.D.F.</given-names></name>
<name><surname>Henz</surname><given-names>N.d.L.F.B.</given-names></name>
<name><surname>Dos Reis</surname><given-names>A.d.S.</given-names></name>
<name><surname>Pinto</surname><given-names>M.S.A.P.</given-names></name>
<etal/>
</person-group><article-title>Persist&#x000ea;ncia Da Hansen&#x000ed;ase Em Redes de Conv&#x000ed;vio Domiciliar: Sobreposi&#x000e7;&#x000e3;o de Casos e Vulnerabilidade Em Regi&#x000f5;es End&#x000ea;micas No Brasil</article-title><source>Cad. Saude Publica</source><year>2019</year><volume>35</volume><fpage>e00105318</fpage><pub-id pub-id-type="doi">10.1590/0102-311x00105318</pub-id><pub-id pub-id-type="pmid">30785488</pub-id>
</element-citation></ref><ref id="B61-tropicalmed-10-00032"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niitsuma</surname><given-names>E.N.A.</given-names></name>
<name><surname>Bueno</surname><given-names>I.D.C.</given-names></name>
<name><surname>Arantes</surname><given-names>E.O.</given-names></name>
<name><surname>Carvalho</surname><given-names>A.P.M.</given-names></name>
<name><surname>Xavier Junior</surname><given-names>G.F.</given-names></name>
<name><surname>Fernandes</surname><given-names>G.d.R.</given-names></name>
<name><surname>Lana</surname><given-names>F.C.F.</given-names></name>
</person-group><article-title>Fatores Associados Ao Adoecimento Por Hansen&#x000ed;ase Em Contatos: Revis&#x000e3;o Sistem&#x000e1;tica e Metan&#x000e1;lise</article-title><source>Rev. Bras. Epidemiol.</source><year>2021</year><volume>24</volume><fpage>e210039</fpage><pub-id pub-id-type="doi">10.1590/1980-549720210039</pub-id><pub-id pub-id-type="pmid">34231829</pub-id>
</element-citation></ref><ref id="B62-tropicalmed-10-00032"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carvalho</surname><given-names>A.P.M.</given-names></name>
<name><surname>Coelho</surname><given-names>A.d.C.O.</given-names></name>
<name><surname>Correa-Oliveira</surname><given-names>R.</given-names></name>
<name><surname>Lana</surname><given-names>F.C.F.</given-names></name>
</person-group><article-title>Specific Antigen Serologic Tests in Leprosy: Implications for Epidemiological Surveillance of Leprosy Cases and Household Contacts</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2017</year><volume>112</volume><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1590/0074-02760160505</pub-id><pub-id pub-id-type="pmid">28902286</pub-id>
</element-citation></ref><ref id="B63-tropicalmed-10-00032"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vidal</surname><given-names>S.L.</given-names></name>
<name><surname>Mattos</surname><given-names>A.M.M.d.</given-names></name>
<name><surname>Menegati</surname><given-names>L.M.</given-names></name>
<name><surname>Monteiro</surname><given-names>T.B.M.</given-names></name>
<name><surname>Laurindo</surname><given-names>C.R.</given-names></name>
<name><surname>Carvalho</surname><given-names>A.P.M.</given-names></name>
<name><surname>Teixeira</surname><given-names>H.C.</given-names></name>
<name><surname>Coelho</surname><given-names>A.d.C.O.</given-names></name>
</person-group><article-title>Testes Sorol&#x000f3;gicos Anti-NDO-HSA, Anti-LID-1 e Anti- NDO-LID Em Contatos Domiciliares de &#x000c1;rea N&#x000e3;o End&#x000ea;mica de Hansen&#x000ed;ase</article-title><source>HU Rev.</source><year>2019</year><volume>44</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.34019/1982-8047.2018.v44.25750</pub-id></element-citation></ref><ref id="B64-tropicalmed-10-00032"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frade</surname><given-names>M.A.C.</given-names></name>
<name><surname>de Paula</surname><given-names>N.A.</given-names></name>
<name><surname>Gomes</surname><given-names>C.M.</given-names></name>
<name><surname>Vernal</surname><given-names>S.</given-names></name>
<name><surname>Bernardes Filho</surname><given-names>F.</given-names></name>
<name><surname>Lug&#x000e3;o</surname><given-names>H.B.</given-names></name>
<name><surname>de Abreu</surname><given-names>M.M.M.</given-names></name>
<name><surname>Botini</surname><given-names>P.</given-names></name>
<name><surname>Duthie</surname><given-names>M.S.</given-names></name>
<name><surname>Spencer</surname><given-names>J.S.</given-names></name>
<etal/>
</person-group><article-title>Unexpectedly High Leprosy Seroprevalence Detected Using a Random Surveillance Strategy in Midwestern Brazil: A Comparison of ELISA and a Rapid Diagnostic Test</article-title><source>PLoS Negl. Trop. Dis.</source><year>2017</year><volume>11</volume><elocation-id>e0005375</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0005375</pub-id><pub-id pub-id-type="pmid">28231244</pub-id>
</element-citation></ref><ref id="B65-tropicalmed-10-00032"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nath</surname><given-names>I.</given-names></name>
<name><surname>Saini</surname><given-names>C.</given-names></name>
<name><surname>Valluri</surname><given-names>V.L.</given-names></name>
</person-group><article-title>Immunology of Leprosy and Diagnostic Challenges</article-title><source>Clin. Dermatol.</source><year>2015</year><volume>33</volume><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2014.07.005</pub-id><pub-id pub-id-type="pmid">25432814</pub-id>
</element-citation></ref><ref id="B66-tropicalmed-10-00032"><label>66.</label><element-citation publication-type="book"><person-group person-group-type="editor">
<collab>Minist&#x000e9;rio da Sa&#x000fa;de</collab>
<collab>Departamento Nacional de Sa&#x000fa;de</collab>
</person-group><source>Brasil Manual de Leprologia</source><publisher-name>Servi&#x000e7;o Nacional de Lepra</publisher-name><publisher-loc>Rio de Janeiro, Bazil</publisher-loc><year>1960</year></element-citation></ref><ref id="B67-tropicalmed-10-00032"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lana</surname><given-names>F.C.F.</given-names></name>
<name><surname>Lanza</surname><given-names>F.M.</given-names></name>
<name><surname>Carvalho</surname><given-names>A.P.M.</given-names></name>
<name><surname>Tavares</surname><given-names>A.P.N.</given-names></name>
</person-group><article-title>O Estigma Em Hansen&#x000ed;ase e Sua Rela&#x000e7;&#x000e3;o Com as A&#x000e7;&#x000f5;es de Controle</article-title><source>Rev. Enferm. UFSM</source><year>2014</year><volume>4</volume><fpage>556</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.5902/2179769212550</pub-id></element-citation></ref><ref id="B68-tropicalmed-10-00032"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marques</surname><given-names>L.&#x000c9;.C.</given-names></name>
<name><surname>Frota</surname><given-names>C.C.</given-names></name>
<name><surname>Quetz</surname><given-names>J.d.S.</given-names></name>
<name><surname>Bind&#x000e1;</surname><given-names>A.H.</given-names></name>
<name><surname>Mota</surname><given-names>R.M.S.</given-names></name>
<name><surname>Pontes</surname><given-names>M.A.d.A.</given-names></name>
<name><surname>Gon&#x000e7;alves</surname><given-names>H.d.S.</given-names></name>
<name><surname>Kendall</surname><given-names>C.</given-names></name>
<name><surname>Kerr</surname><given-names>L.R.F.S.</given-names></name>
</person-group><article-title>Evaluation of 16S RRNA QPCR for Detection of <italic toggle="yes">Mycobacterium leprae</italic> DNA in Nasal Secretion and Skin Biopsy Samples from Multibacillary and Paucibacillary Leprosy Cases</article-title><source>Pathog. Glob. Health</source><year>2018</year><volume>112</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1080/20477724.2017.1415736</pub-id><pub-id pub-id-type="pmid">29279044</pub-id>
</element-citation></ref><ref id="B69-tropicalmed-10-00032"><label>69.</label><element-citation publication-type="webpage"><article-title>Doen&#x000e7;as Infecciosas e Parasit&#x000e1;rias&#x02014;BVS Doen&#x000e7;as Infecciosas e Parasit&#x000e1;rias</article-title><comment>Available online: <ext-link xlink:href="https://www.bvsdip.icict.fiocruz.br/doencas-infecciosas-e-parasitarias" ext-link-type="uri">https://www.bvsdip.icict.fiocruz.br/doencas-infecciosas-e-parasitarias</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-08-15">(accessed on 15 August 2024)</date-in-citation></element-citation></ref><ref id="B70-tropicalmed-10-00032"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Corr&#x000ea;a</surname><given-names>C.M.</given-names></name>
<name><surname>Lanza</surname><given-names>F.M.</given-names></name>
<name><surname>Carvalho</surname><given-names>A.P.M.</given-names></name>
<name><surname>Lana</surname><given-names>F.C.F.</given-names></name>
</person-group><article-title>Di&#x000e1;logos Sobre a Descentraliza&#x000e7;&#x000e3;o Do Programa de Controle Da Hansen&#x000ed;ase Em Munic&#x000ed;pio End&#x000ea;mico: Uma Avalia&#x000e7;&#x000e3;o Participativa</article-title><source>Esc. Anna Nery</source><year>2021</year><volume>26</volume><fpage>2022</fpage><pub-id pub-id-type="doi">10.1590/2177-9465-ean-2021-0114</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="tropicalmed-10-00032-f001"><label>Figure 1</label><caption><p>Flowchart of the pathogenesis of leprosy.</p></caption><graphic xlink:href="tropicalmed-10-00032-g001" position="float"/></fig><fig position="float" id="tropicalmed-10-00032-f002"><label>Figure 2</label><caption><p>PRISMA diagram: the process of selecting eligible studies for the systematic review.</p></caption><graphic xlink:href="tropicalmed-10-00032-g002" position="float"/></fig><table-wrap position="float" id="tropicalmed-10-00032-t001"><object-id pub-id-type="pii">tropicalmed-10-00032-t001_Table 1</object-id><label>Table 1</label><caption><p><italic toggle="yes">M. leprae</italic> DNA positivity among the studies included in the systematic review.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecular Target</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Analysis Technique</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Material Analyzed</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">M. leprae</italic> DNA Positivity</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">RLEP</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Dermal scrapings</td><td align="left" valign="middle" rowspan="1" colspan="1">3.12% to 21.43%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B18-tropicalmed-10-00032" ref-type="bibr">18</xref>,<xref rid="B19-tropicalmed-10-00032" ref-type="bibr">19</xref>,<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Blood</td><td align="left" valign="middle" rowspan="1" colspan="1">1.7% to 6.25%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B20-tropicalmed-10-00032" ref-type="bibr">20</xref>,<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" rowspan="1" colspan="1">1.7% to 72.2%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B19-tropicalmed-10-00032" ref-type="bibr">19</xref>,<xref rid="B21-tropicalmed-10-00032" ref-type="bibr">21</xref>,<xref rid="B22-tropicalmed-10-00032" ref-type="bibr">22</xref>,<xref rid="B23-tropicalmed-10-00032" ref-type="bibr">23</xref>,<xref rid="B24-tropicalmed-10-00032" ref-type="bibr">24</xref>,<xref rid="B25-tropicalmed-10-00032" ref-type="bibr">25</xref>,<xref rid="B26-tropicalmed-10-00032" ref-type="bibr">26</xref>,<xref rid="B27-tropicalmed-10-00032" ref-type="bibr">27</xref>,<xref rid="B28-tropicalmed-10-00032" ref-type="bibr">28</xref>,<xref rid="B29-tropicalmed-10-00032" ref-type="bibr">29</xref>,<xref rid="B31-tropicalmed-10-00032" ref-type="bibr">31</xref>,<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oral swab</td><td align="left" valign="middle" rowspan="1" colspan="1">5.6% a 6.83%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B29-tropicalmed-10-00032" ref-type="bibr">29</xref>,<xref rid="B30-tropicalmed-10-00032" ref-type="bibr">30</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saliva</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.9% in household contacts and 12.5% peridomiciliary contacts</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">qPCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Nasal biposy</td><td align="left" valign="middle" rowspan="1" colspan="1">53.8%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dermal scrapings</td><td align="left" valign="middle" rowspan="1" colspan="1">23.7% to 78.7%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B32-tropicalmed-10-00032" ref-type="bibr">32</xref>,<xref rid="B33-tropicalmed-10-00032" ref-type="bibr">33</xref>,<xref rid="B34-tropicalmed-10-00032" ref-type="bibr">34</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" rowspan="1" colspan="1">4.7% to 49%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>,<xref rid="B35-tropicalmed-10-00032" ref-type="bibr">35</xref>,<xref rid="B36-tropicalmed-10-00032" ref-type="bibr">36</xref>,<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Blood</td><td align="left" valign="middle" rowspan="1" colspan="1">6.7%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B14-tropicalmed-10-00032" ref-type="bibr">14</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palate scrapings</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31%</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">16S</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Saliva</td><td align="left" valign="middle" rowspan="1" colspan="1">An amount of 2.4% in household contacts and 2.5% in peridomiciliary contacts</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-tropicalmed-10-00032" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4%</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">qPCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Dermal scrapings</td><td align="left" valign="middle" rowspan="1" colspan="1">9% to 16.81%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>,<xref rid="B41-tropicalmed-10-00032" ref-type="bibr">41</xref>,<xref rid="B42-tropicalmed-10-00032" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.73%</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-tropicalmed-10-00032" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Other molecular targets</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">PCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" rowspan="1" colspan="1">0% to 31%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-tropicalmed-10-00032" ref-type="bibr">38</xref>,<xref rid="B43-tropicalmed-10-00032" ref-type="bibr">43</xref>,<xref rid="B44-tropicalmed-10-00032" ref-type="bibr">44</xref>,<xref rid="B45-tropicalmed-10-00032" ref-type="bibr">45</xref>,<xref rid="B46-tropicalmed-10-00032" ref-type="bibr">46</xref>,<xref rid="B47-tropicalmed-10-00032" ref-type="bibr">47</xref>,<xref rid="B48-tropicalmed-10-00032" ref-type="bibr">48</xref>,<xref rid="B49-tropicalmed-10-00032" ref-type="bibr">49</xref>,<xref rid="B50-tropicalmed-10-00032" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermal scrapings</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.2%</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-tropicalmed-10-00032" ref-type="bibr">50</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">qPCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" rowspan="1" colspan="1">19%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Palate scrapings</td><td align="left" valign="middle" rowspan="1" colspan="1">13%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B39-tropicalmed-10-00032" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Blood</td><td align="left" valign="middle" rowspan="1" colspan="1">1.2%</td><td align="left" valign="middle" rowspan="1" colspan="1">[<xref rid="B51-tropicalmed-10-00032" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nasal swab</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.35%</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-tropicalmed-10-00032" ref-type="bibr">52</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>